Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:coumestrol
go back to main search page
Accession:CHEBI:3908 term browser browse the term
Definition:A member of the class of coumestans that is coumestan with hydroxy substituents at positions 3 and 9.
Synonyms:related_synonym: 3,9-Dihydroxy-6H-[1]benzofuro[3,2-c]chromen-6-one;   3,9-dihydroxycoumestan;   Chrysanthin;   Formula=C15H8O5;   InChI=1S/C15H8O5/c16-7-1-3-9-11(5-7)19-14-10-4-2-8(17)6-12(10)20-15(18)13(9)14/h1-6,16-17H;   InChIKey=ZZIALNLLNHEQPJ-UHFFFAOYSA-N;   SMILES=Oc1ccc2c(c1)oc1c3ccc(O)cc3oc(=O)c21
 xref: CAS:479-13-0;   HMDB:HMDB0002326;   KEGG:C10205;   KNApSAcK:C00002514;   LINCS:LSM-4202;   LIPID_MAPS_instance:LMPK12090018
 xref_mesh: MESH:D003375
 xref: MetaCyc:CPD-11779;   PMID:22644850;   PMID:22694330;   PMID:22824334;   PMID:22926873;   PMID:23348407;   Reaxys:266702;   Wikipedia:Coumestrol


show annotations for term's descendants           Sort by:
 
coumestrol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aaas aladin WD repeat nucleoporin multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AAAS mRNA
Coumestrol results in increased expression of AAAS mRNA
CTD PMID:19167446 NCBI chr 7:143,937,198...143,956,668
Ensembl chr 7:143,937,199...143,956,668
JBrowse link
G Aars1 alanyl-tRNA synthetase 1 increases expression ISO Coumestrol results in increased expression of AARS1 mRNA CTD PMID:19167446 NCBI chr19:43,193,264...43,215,281
Ensembl chr19:43,193,257...43,215,281
JBrowse link
G Abat 4-aminobutyrate aminotransferase increases expression ISO Coumestrol results in increased expression of ABAT mRNA CTD PMID:19167446 NCBI chr10:7,093,406...7,200,439
Ensembl chr10:7,093,405...7,200,499
JBrowse link
G Abcc5 ATP binding cassette subfamily C member 5 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ABCC5 mRNA CTD PMID:19167446 NCBI chr11:84,395,982...84,490,215
Ensembl chr11:84,396,033...84,490,211
JBrowse link
G Abcd3 ATP binding cassette subfamily D member 3 decreases expression ISO Coumestrol results in decreased expression of ABCD3 mRNA CTD PMID:19167446 NCBI chr 2:225,335,708...225,389,120
Ensembl chr 2:225,335,718...225,389,120
JBrowse link
G Abce1 ATP binding cassette subfamily E member 1 increases expression ISO Coumestrol results in increased expression of ABCE1 mRNA CTD PMID:19167446 NCBI chr19:31,867,960...31,892,863
Ensembl chr19:31,867,981...31,892,863
JBrowse link
G Abcf1 ATP binding cassette subfamily F member 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ABCF1 mRNA
Coumestrol results in increased expression of ABCF1 mRNA
CTD PMID:19167446 NCBI chr20:3,309,914...3,322,828
Ensembl chr20:3,309,899...3,322,825
JBrowse link
G Abcg1 ATP binding cassette subfamily G member 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ABCG1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of ABCG1 mRNA CTD PMID:19167446 NCBI chr20:9,743,269...9,842,735
Ensembl chr20:9,743,269...9,840,489
JBrowse link
G Abhd11 abhydrolase domain containing 11 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of ABHD11 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ABHD11 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of ABHD11 mRNA
CTD PMID:19167446 NCBI chr12:24,722,277...24,725,760
Ensembl chr12:24,722,283...24,724,997
JBrowse link
G Abhd12 abhydrolase domain containing 12, lysophospholipase multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ABHD12 mRNA CTD PMID:19167446 NCBI chr 3:146,630,298...146,690,375
Ensembl chr 3:146,630,299...146,690,375
JBrowse link
G Abhd16a abhydrolase domain containing 16A, phospholipase decreases expression ISO Coumestrol results in decreased expression of ABHD16A mRNA CTD PMID:19167446 NCBI chr20:5,080,070...5,094,935
Ensembl chr20:5,080,070...5,094,935
JBrowse link
G Abi1 abl-interactor 1 decreases expression ISO Coumestrol results in decreased expression of ABI1 mRNA CTD PMID:19167446 NCBI chr17:89,951,662...90,033,334
Ensembl chr17:89,951,752...90,033,328
JBrowse link
G Abraxas1 abraxas 1, BRCA1 A complex subunit decreases expression ISO Coumestrol results in decreased expression of ABRAXAS1 mRNA CTD PMID:19167446 NCBI chr14:10,424,674...10,439,010
Ensembl chr14:10,424,674...10,439,003
JBrowse link
G Acaa2 acetyl-CoA acyltransferase 2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ACAA2 mRNA CTD PMID:19167446 NCBI chr18:70,733,872...70,762,395
Ensembl chr18:70,733,872...70,762,395
JBrowse link
G Acat2 acetyl-CoA acetyltransferase 2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACAT2 mRNA
Coumestrol results in increased expression of ACAT2 mRNA
CTD PMID:19167446 NCBI chr 1:47,972,399...47,992,654
Ensembl chr 1:47,972,399...47,992,653
JBrowse link
G Acbd3 acyl-CoA binding domain containing 3 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ACBD3 mRNA CTD PMID:19167446 NCBI chr13:99,004,942...99,035,520
Ensembl chr13:99,004,942...99,035,519
JBrowse link
G Ackr3 atypical chemokine receptor 3 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ACKR3 mRNA CTD PMID:19167446 NCBI chr 9:97,355,881...97,367,455
Ensembl chr 9:97,355,924...97,367,445
JBrowse link
G Acly ATP citrate lyase multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACLY mRNA
Coumestrol results in increased expression of ACLY mRNA
CTD PMID:19167446 NCBI chr10:88,392,248...88,442,845
Ensembl chr10:88,392,248...88,442,845
JBrowse link
G Acot4 acyl-CoA thioesterase 4 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACOT4 mRNA; [Coumestrol co-treated with Resveratrol] results in increased expression of ACOT4 mRNA
Coumestrol results in increased expression of ACOT4 mRNA
CTD PMID:19167446 NCBI chr 6:107,517,668...107,522,952
Ensembl chr 6:107,517,668...107,522,952
JBrowse link
G Acot7 acyl-CoA thioesterase 7 increases expression
multiple interactions
ISO Coumestrol results in increased expression of ACOT7 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACOT7 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ACOT7 mRNA
CTD PMID:19167446 NCBI chr 5:169,357,582...169,450,215
Ensembl chr 5:169,357,517...169,450,219
JBrowse link
G Acsl3 acyl-CoA synthetase long-chain family member 3 decreases expression ISO Coumestrol results in decreased expression of ACSL3 mRNA CTD PMID:19167446 NCBI chr 9:84,569,601...84,593,565
Ensembl chr 9:84,569,597...84,593,565
JBrowse link
G Acss3 acyl-CoA synthetase short-chain family member 3 decreases expression ISO Coumestrol results in decreased expression of ACSS3 mRNA CTD PMID:19167446 NCBI chr 7:49,047,022...49,250,953
Ensembl chr 7:49,047,013...49,250,957
JBrowse link
G Acvr1 activin A receptor type 1 decreases expression ISO Coumestrol results in decreased expression of ACVR1 mRNA CTD PMID:19167446 NCBI chr 3:44,432,476...44,539,680
Ensembl chr 3:44,432,471...44,522,930
JBrowse link
G Acyp1 acylphosphatase 1 increases expression
multiple interactions
ISO Coumestrol results in increased expression of ACYP1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACYP1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ACYP1 mRNA
CTD PMID:19167446 NCBI chr 6:109,097,065...109,110,266
Ensembl chr 6:109,097,065...109,104,050
JBrowse link
G Adat1 adenosine deaminase, tRNA-specific 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ADAT1 mRNA CTD PMID:19167446 NCBI chr19:44,172,496...44,212,147
Ensembl chr19:44,187,331...44,211,208
JBrowse link
G Add3 adducin 3 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ADD3 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ADD3 mRNA
Coumestrol results in increased expression of ADD3 mRNA
CTD PMID:19167446 NCBI chr 1:273,854,195...273,961,982
Ensembl chr 1:273,854,248...273,961,982
JBrowse link
G Adk adenosine kinase increases expression ISO Coumestrol results in increased expression of ADK mRNA CTD PMID:19167446 NCBI chr15:3,033,535...3,435,888
Ensembl chr15:3,033,495...3,435,888
JBrowse link
G Adra2a adrenoceptor alpha 2A multiple interactions ISO [Coumestrol co-treated with ESR1 protein] results in increased expression of ADRA2A mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of ADRA2A mRNA] CTD PMID:18310284 NCBI chr 1:274,766,283...274,769,083
Ensembl chr 1:274,766,283...274,769,081
JBrowse link
G Afap1 actin filament associated protein 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AFAP1 mRNA CTD PMID:19167446 NCBI chr14:79,923,132...80,035,096
Ensembl chr14:79,919,717...79,988,110
JBrowse link
G Aff4 AF4/FMR2 family, member 4 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AFF4 mRNA
Coumestrol results in decreased expression of AFF4 mRNA
CTD PMID:19167446 NCBI chr10:38,692,167...38,773,021
Ensembl chr10:38,692,211...38,773,021
JBrowse link
G Afp alpha-fetoprotein affects binding EXP Coumestrol binds to AFP protein CTD PMID:23013281, PMID:25349334 NCBI chr14:19,141,755...19,159,919
Ensembl chr14:19,141,755...19,159,923
JBrowse link
G Agap1 ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 decreases expression ISO Coumestrol results in decreased expression of AGAP1 mRNA CTD PMID:19167446 NCBI chr 9:96,718,901...97,034,400
Ensembl chr 9:96,621,586...97,030,163
JBrowse link
G Ago2 argonaute RISC catalytic component 2 decreases expression ISO Coumestrol results in decreased expression of AGO2 mRNA CTD PMID:19167446 NCBI chr 7:114,339,607...114,377,277
Ensembl chr 7:114,339,434...114,380,613
JBrowse link
G Agpat3 1-acylglycerol-3-phosphate O-acyltransferase 3 decreases expression ISO Coumestrol results in decreased expression of AGPAT3 mRNA CTD PMID:19167446 NCBI chr20:11,060,584...11,144,806
Ensembl chr20:11,114,164...11,144,806
JBrowse link
G Agr2 anterior gradient 2, protein disulphide isomerase family member multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AGR2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of AGR2 mRNA
Coumestrol results in increased expression of AGR2 mRNA
CTD PMID:19167446 NCBI chr 6:55,465,782...55,487,087
Ensembl chr 6:55,465,782...55,487,714
JBrowse link
G Agr3 anterior gradient 3, protein disulphide isomerase family member multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AGR3 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of AGR3 mRNA
Coumestrol results in increased expression of AGR3 mRNA
CTD PMID:19167446 NCBI chr 6:55,371,738...55,424,233
Ensembl chr 6:55,371,738...55,424,674
JBrowse link
G Agtrap angiotensin II receptor-associated protein increases expression ISO Coumestrol results in increased expression of AGTRAP mRNA CTD PMID:19167446 NCBI chr 5:164,888,069...164,898,387
Ensembl chr 5:164,886,813...164,898,420
JBrowse link
G Ahcyl1 adenosylhomocysteinase-like 1 decreases expression ISO Coumestrol results in decreased expression of AHCYL1 mRNA CTD PMID:19167446 NCBI chr 2:210,438,884...210,474,350
Ensembl chr 2:210,438,893...210,473,761
JBrowse link
G Ahsa1 activator of Hsp90 ATPase activity 1 increases expression ISO Coumestrol results in increased expression of AHSA1 mRNA CTD PMID:19167446 NCBI chr 6:111,296,168...111,304,224
Ensembl chr 6:111,296,417...111,304,224
JBrowse link
G Ajuba ajuba LIM protein multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AJUBA mRNA
Coumestrol results in decreased expression of AJUBA mRNA
CTD PMID:19167446 NCBI chr15:33,208,210...33,218,456
Ensembl chr15:33,208,216...33,218,456
JBrowse link
G Akap13 A-kinase anchoring protein 13 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of AKAP13 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AKAP13 mRNA
CTD PMID:19167446 NCBI chr 1:137,089,558...137,315,272
Ensembl chr 1:137,014,272...137,315,272
JBrowse link
G Alcam activated leukocyte cell adhesion molecule decreases expression ISO Coumestrol results in decreased expression of ALCAM mRNA CTD PMID:19167446 NCBI chr11:50,780,735...50,985,083
Ensembl chr11:50,781,127...50,985,083
JBrowse link
G Aldh16a1 aldehyde dehydrogenase 16 family, member A1 increases expression ISO Coumestrol results in increased expression of ALDH16A1 mRNA CTD PMID:19167446 NCBI chr 1:101,138,237...101,151,320
Ensembl chr 1:101,138,248...101,151,320
JBrowse link
G Aldh3b2 aldehyde dehydrogenase 3 family, member B2 multiple interactions
decreases expression
ISO [Coumestrol co-treated with resveratrol] results in decreased expression of ALDH3B2 mRNA
Coumestrol results in decreased expression of ALDH3B2 mRNA
CTD PMID:19167446 NCBI chr 1:219,215,023...219,218,488 JBrowse link
G Aldh4a1 aldehyde dehydrogenase 4 family, member A1 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of ALDH4A1 mRNA CTD PMID:19167446 NCBI chr 5:158,090,238...158,115,725
Ensembl chr 5:158,042,587...158,135,733
JBrowse link
G Alg6 ALG6, alpha-1,3-glucosyltransferase multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ALG6 mRNA
Coumestrol results in increased expression of ALG6 mRNA
CTD PMID:19167446 NCBI chr 5:118,415,680...118,470,634
Ensembl chr 5:118,418,799...118,469,376
JBrowse link
G Alg8 ALG8, alpha-1,3-glucosyltransferase increases expression
multiple interactions
ISO Coumestrol results in increased expression of ALG8 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ALG8 mRNA
CTD PMID:19167446 NCBI chr 1:162,342,061...162,362,139
Ensembl chr 1:162,342,051...162,362,141
JBrowse link
G Alkbh7 alkB homolog 7 decreases expression ISO Coumestrol results in decreased expression of ALKBH7 mRNA CTD PMID:19167446 NCBI chr 9:10,045,375...10,047,507
Ensembl chr 9:10,045,375...10,047,507
JBrowse link
G Alpl alkaline phosphatase, biomineralization associated multiple interactions ISO [Coumestrol binds to ESR1 protein] which results in increased activity of ALPL protein; fulvestrant inhibits the reaction [[Coumestrol binds to ESR1 protein] which results in increased activity of ALPL protein] CTD PMID:12650720 NCBI chr 5:156,086,496...156,141,513
Ensembl chr 5:156,086,497...156,141,537
JBrowse link
G Als2 alsin Rho guanine nucleotide exchange factor ALS2 decreases expression ISO Coumestrol results in decreased expression of ALS2 mRNA CTD PMID:19167446 NCBI chr 9:65,961,361...66,034,396
Ensembl chr 9:65,961,346...66,033,871
JBrowse link
G Alyref Aly/REF export factor increases expression ISO Coumestrol results in increased expression of ALYREF mRNA CTD PMID:19167446 NCBI chr10:109,768,593...109,774,639
Ensembl chr10:109,770,876...109,774,639
JBrowse link
G Amd1 adenosylmethionine decarboxylase 1 increases expression
multiple interactions
ISO Coumestrol results in increased expression of AMD1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AMD1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of AMD1 mRNA
CTD PMID:19167446 NCBI chr20:45,384,000...45,399,694
Ensembl chr20:45,384,000...45,399,694
JBrowse link
G Amfr autocrine motility factor receptor multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of AMFR mRNA CTD PMID:19167446 NCBI chr19:11,473,538...11,509,500
Ensembl chr19:11,473,541...11,508,102
JBrowse link
G Ammecr1 AMMECR nuclear protein 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AMMECR1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of AMMECR1 mRNA
Coumestrol results in increased expression of AMMECR1 mRNA
CTD PMID:19167446 NCBI chr  X:114,129,829...114,233,013
Ensembl chr  X:114,131,898...114,232,939
JBrowse link
G Amotl2 angiomotin like 2 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of AMOTL2 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AMOTL2 mRNA
CTD PMID:19167446 NCBI chr 8:111,210,261...111,226,217
Ensembl chr 8:111,209,908...111,226,226
JBrowse link
G Anapc5 anaphase-promoting complex subunit 5 increases expression ISO Coumestrol results in increased expression of ANAPC5 mRNA CTD PMID:19167446 NCBI chr12:39,209,134...39,242,696
Ensembl chr12:39,209,129...39,242,690
JBrowse link
G Anapc7 anaphase promoting complex subunit 7 increases expression ISO Coumestrol results in increased expression of ANAPC7 mRNA CTD PMID:19167446 NCBI chr12:39,613,898...39,641,999
Ensembl chr12:39,614,733...39,641,285
JBrowse link
G Anln anillin, actin binding protein multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ANLN mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of ANLN mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ANLN mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of ANLN mRNA]
Coumestrol results in increased expression of ANLN mRNA
CTD PMID:18310284, PMID:19167446 NCBI chr 8:23,336,455...23,397,122
Ensembl chr 8:23,337,621...23,390,773
JBrowse link
G Ano6 anoctamin 6 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANO6 mRNA
Coumestrol results in decreased expression of ANO6 mRNA
CTD PMID:19167446 NCBI chr 7:137,142,063...137,335,208
Ensembl chr 7:137,142,170...137,335,208
JBrowse link
G Anp32a acidic nuclear phosphoprotein 32 family member A increases expression ISO Coumestrol results in increased expression of ANP32A mRNA CTD PMID:19167446 NCBI chr 8:67,295,578...67,333,075
Ensembl chr 8:67,295,727...67,333,247
JBrowse link
G Anp32e acidic nuclear phosphoprotein 32 family member E multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ANP32E mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of ANP32E mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ANP32E mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of ANP32E mRNA]
Coumestrol results in increased expression of ANP32E mRNA
CTD PMID:18310284, PMID:19167446 NCBI chr 2:198,040,573...198,057,005
Ensembl chr 2:198,040,536...198,057,003
JBrowse link
G Anxa2 annexin A2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANXA2 mRNA CTD PMID:19167446 NCBI chr 8:75,687,134...75,723,589
Ensembl chr 8:75,687,100...75,723,594
JBrowse link
G Anxa3 annexin A3 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANXA3 mRNA CTD PMID:19167446 NCBI chr14:14,371,921...14,426,503
Ensembl chr14:14,364,008...14,426,437
JBrowse link
G Anxa9 annexin A9 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ANXA9 mRNA CTD PMID:19167446 NCBI chr 2:196,470,318...196,481,568
Ensembl chr 2:196,470,858...196,479,770
JBrowse link
G Ap1b1 adaptor related protein complex 1 subunit beta 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AP1B1 mRNA CTD PMID:19167446 NCBI chr14:85,230,652...85,281,806
Ensembl chr14:85,230,648...85,281,803
JBrowse link
G Ap1m1 adaptor related protein complex 1 subunit mu 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AP1M1 mRNA CTD PMID:19167446 NCBI chr16:19,288,354...19,303,818
Ensembl chr16:19,288,355...19,303,824
JBrowse link
G Ap2s1 adaptor related protein complex 2 subunit sigma 1 increases expression ISO Coumestrol results in increased expression of AP2S1 mRNA CTD PMID:19167446 NCBI chr 1:78,671,238...78,682,847
Ensembl chr 1:78,671,121...78,682,871
JBrowse link
G Apbb2 amyloid beta precursor protein binding family B member 2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of APBB2 mRNA CTD PMID:19167446 NCBI chr14:43,205,047...43,526,968
Ensembl chr14:43,512,901...43,523,080
JBrowse link
G Apod apolipoprotein D decreases expression ISO Coumestrol results in decreased expression of APOD mRNA CTD PMID:19167446 NCBI chr11:72,705,204...72,726,263
Ensembl chr11:72,705,129...72,726,301
JBrowse link
G App amyloid beta precursor protein decreases expression ISO Coumestrol results in decreased expression of APP mRNA CTD PMID:19167446 NCBI chr11:24,425,013...24,641,872
Ensembl chr11:24,425,005...24,641,858
JBrowse link
G Aqp3 aquaporin 3 (Gill blood group) decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of AQP3 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AQP3 mRNA
CTD PMID:19167446 NCBI chr 5:57,423,735...57,429,252
Ensembl chr 5:57,423,734...57,429,245
JBrowse link
G Ar androgen receptor decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of AR mRNA
Coumestrol inhibits the reaction [Stanozolol binds to and results in increased activity of AR protein]
CTD PMID:11867264, PMID:29162470 NCBI chr  X:67,656,253...67,828,998
Ensembl chr  X:67,656,253...67,829,026
JBrowse link
G Arfgef2 ADP ribosylation factor guanine nucleotide exchange factor 2 decreases expression ISO Coumestrol results in decreased expression of ARFGEF2 mRNA CTD PMID:19167446 NCBI chr 3:163,570,435...163,656,612
Ensembl chr 3:163,570,532...163,656,626
JBrowse link
G Arfgef3 ARFGEF family member 3 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ARFGEF3 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of ARFGEF3 mRNA
Coumestrol results in decreased expression of ARFGEF3 mRNA
CTD PMID:19167446 NCBI chr 1:13,837,861...13,918,277
Ensembl chr 1:13,838,707...13,915,594
JBrowse link
G Arhgap19 Rho GTPase activating protein 19 increases expression ISO Coumestrol results in increased expression of ARHGAP19 mRNA CTD PMID:19167446 NCBI chr 1:261,015,083...261,051,515
Ensembl chr 1:261,015,123...261,051,498
JBrowse link
G Arhgap39 Rho GTPase activating protein 39 decreases expression ISO Coumestrol results in decreased expression of ARHGAP39 mRNA CTD PMID:19167446 NCBI chr 7:117,788,716...117,880,329
Ensembl chr 7:117,788,716...117,880,289
JBrowse link
G Arhgdia Rho GDP dissociation inhibitor alpha multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARHGDIA mRNA CTD PMID:19167446 NCBI chr10:109,754,012...109,757,506
Ensembl chr10:109,754,004...109,757,550
JBrowse link
G Arhgef26 Rho guanine nucleotide exchange factor 26 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARHGEF26 mRNA
Coumestrol results in increased expression of ARHGEF26 mRNA
CTD PMID:19167446 NCBI chr 2:27,107,263...27,236,336
Ensembl chr 2:27,107,318...27,236,672
JBrowse link
G Arhgef37 Rho guanine nucleotide exchange factor 37 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ARHGEF37 mRNA CTD PMID:19167446 NCBI chr18:56,817,986...56,871,159
Ensembl chr18:56,817,988...56,870,839
JBrowse link
G Arhgef39 Rho guanine nucleotide exchange factor 39 increases expression ISO Coumestrol results in increased expression of ARHGEF39 mRNA CTD PMID:19167446 NCBI chr 5:58,998,209...59,001,779
Ensembl chr 5:58,995,249...59,001,800
JBrowse link
G Arid4b AT-rich interaction domain 4B decreases expression ISO Coumestrol results in decreased expression of ARID4B mRNA CTD PMID:19167446 NCBI chr17:53,831,353...53,955,897
Ensembl chr17:53,833,023...53,915,076
JBrowse link
G Arl3 ADP ribosylation factor like GTPase 3 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARL3 mRNA; [Coumestrol co-treated with Resveratrol] results in increased expression of ARL3 mRNA CTD PMID:19167446 NCBI chr 1:266,287,015...266,333,099
Ensembl chr 1:266,287,017...266,333,105
JBrowse link
G Arnt aryl hydrocarbon receptor nuclear translocator decreases expression ISO Coumestrol results in decreased expression of ARNT mRNA CTD PMID:19167446 NCBI chr 2:196,594,178...196,651,486
Ensembl chr 2:196,594,303...196,651,179
JBrowse link
G Arrdc3 arrestin domain containing 3 decreases expression ISO Coumestrol results in decreased expression of ARRDC3 mRNA CTD PMID:19167446 NCBI chr 2:8,732,907...8,745,445
Ensembl chr 2:8,732,932...8,743,069
JBrowse link
G Arx aristaless related homeobox multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ARX mRNA CTD PMID:19167446 NCBI chr  X:62,363,757...62,376,139
Ensembl chr  X:62,363,757...62,376,143
JBrowse link
G Asap1 ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of ASAP1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ASAP1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of ASAP1 mRNA
CTD PMID:19167446 NCBI chr 7:104,670,076...104,951,090
Ensembl chr 7:104,669,672...104,801,045
JBrowse link
G Asf1b anti-silencing function 1B histone chaperone increases expression
multiple interactions
ISO Coumestrol results in increased expression of ASF1B mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ASF1B mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ASF1B mRNA
CTD PMID:19167446 NCBI chr19:25,077,918...25,092,491
Ensembl chr19:25,077,918...25,092,491
JBrowse link
G Aspm assembly factor for spindle microtubules multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ASPM mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of ASPM mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ASPM mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of ASPM mRNA]
Coumestrol results in increased expression of ASPM mRNA
CTD PMID:18310284, PMID:19167446 NCBI chr13:56,546,021...56,591,793
Ensembl chr13:56,546,021...56,591,793
JBrowse link
G Atad2 ATPase family, AAA domain containing 2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATAD2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ATAD2 mRNA
Coumestrol results in increased expression of ATAD2 mRNA
CTD PMID:19167446 NCBI chr 7:97,984,754...98,027,379
Ensembl chr 7:97,984,862...98,026,052
JBrowse link
G Atf2 activating transcription factor 2 increases expression ISO Coumestrol results in increased expression of ATF2 mRNA CTD PMID:19167446 NCBI chr 3:60,721,137...60,795,951
Ensembl chr 3:60,721,135...60,795,951
JBrowse link
G Atf3 activating transcription factor 3 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATF3 mRNA
Coumestrol results in decreased expression of ATF3 mRNA
CTD PMID:19167446 NCBI chr13:109,817,892...109,849,632
Ensembl chr13:109,817,728...109,849,632
JBrowse link
G Atf5 activating transcription factor 5 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATF5 mRNA CTD PMID:19167446 NCBI chr 1:100,807,821...100,812,410
Ensembl chr 1:100,808,241...100,810,522
JBrowse link
G Atg14 autophagy related 14 decreases expression ISO Coumestrol results in decreased expression of ATG14 mRNA CTD PMID:19167446 NCBI chr15:24,343,418...24,374,776
Ensembl chr15:24,343,314...24,374,753
JBrowse link
G Atp1b1 ATPase Na+/K+ transporting subunit beta 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP1B1 mRNA CTD PMID:19167446 NCBI chr13:82,737,161...82,757,681
Ensembl chr13:82,737,159...82,758,004
JBrowse link
G Atp23 ATP23 metallopeptidase and ATP synthase assembly factor homolog multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATP23 mRNA
Coumestrol results in increased expression of ATP23 mRNA
CTD PMID:19167446 NCBI chr 7:70,183,625...70,198,655
Ensembl chr 7:70,183,625...70,198,655
JBrowse link
G Atp2a3 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of ATP2A3 mRNA CTD PMID:19167446 NCBI chr10:59,528,849...59,560,440
Ensembl chr10:59,529,785...59,560,433
JBrowse link
G Atp2b1 ATPase plasma membrane Ca2+ transporting 1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP2B1 mRNA
Coumestrol results in decreased expression of ATP2B1 mRNA
CTD PMID:19167446 NCBI chr 7:41,114,606...41,223,138
Ensembl chr 7:41,114,697...41,220,579
JBrowse link
G Atp2c1 ATPase secretory pathway Ca2+ transporting 1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP2C1 mRNA
Coumestrol results in decreased expression of ATP2C1 mRNA
CTD PMID:19167446 NCBI chr 8:113,953,959...114,039,965
Ensembl chr 8:113,955,647...114,013,623
JBrowse link
G Atp5mc1 ATP synthase membrane subunit c locus 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATP5MC1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ATP5MC1 mRNA
Coumestrol results in increased expression of ATP5MC1 mRNA
CTD PMID:19167446 NCBI chr10:83,895,941...83,898,640
Ensembl chr10:83,895,947...83,898,527
JBrowse link
G Atp6v0e1 ATPase H+ transporting V0 subunit e1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP6V0E1 mRNA
Coumestrol results in decreased expression of ATP6V0E1 mRNA
CTD PMID:19167446 NCBI chr10:16,769,857...16,792,930
Ensembl chr10:16,769,666...16,792,909
JBrowse link
G Atp8b1 ATPase phospholipid transporting 8B1 decreases expression ISO Coumestrol results in decreased expression of ATP8B1 mRNA CTD PMID:19167446 NCBI chr18:60,013,388...60,152,920
Ensembl chr18:60,013,382...60,095,354
JBrowse link
G Atp8b2 ATPase phospholipid transporting 8B2 multiple interactions
decreases expression
ISO [Coumestrol co-treated with resveratrol] results in decreased expression of ATP8B2 mRNA
Coumestrol results in decreased expression of ATP8B2 mRNA
CTD PMID:19167446 NCBI chr 2:189,285,961...189,306,947
Ensembl chr 2:189,285,953...189,307,108
JBrowse link
G Atp9a ATPase phospholipid transporting 9A (putative) decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of ATP9A mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP9A mRNA
CTD PMID:19167446 NCBI chr 3:165,405,588...165,511,104
Ensembl chr 3:165,412,803...165,477,771
JBrowse link
G Atxn1 ataxin 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATXN1 mRNA CTD PMID:19167446 NCBI chr17:19,160,986...19,533,814
Ensembl chr17:19,249,952...19,533,814
JBrowse link
G Aurka aurora kinase A multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AURKA mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of AURKA mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of AURKA mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of AURKA mRNA]
Coumestrol results in increased expression of AURKA mRNA
CTD PMID:18310284, PMID:19167446 NCBI chr 3:170,364,177...170,380,278
Ensembl chr 3:170,364,181...170,378,210
JBrowse link
G Aurkb aurora kinase B multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AURKB mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of AURKB mRNA
Coumestrol results in increased expression of AURKB mRNA
CTD PMID:19167446 NCBI chr10:55,625,860...55,632,399
Ensembl chr10:55,626,741...55,634,991
JBrowse link
G Auts2 activator of transcription and developmental regulator AUTS2 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of AUTS2 mRNA
[Coumestrol co-treated with resveratrol] results in decreased expression of AUTS2 mRNA
CTD PMID:19167446 NCBI chr12:27,155,362...28,252,752
Ensembl chr12:28,212,333...28,251,816
JBrowse link
G B2m beta-2 microglobulin increases expression ISO Coumestrol results in increased expression of B2M mRNA CTD PMID:19167446 NCBI chr 3:114,087,287...114,093,311
Ensembl chr 3:114,087,287...114,093,309
JBrowse link
G B3galnt1 beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of B3GALNT1 mRNA CTD PMID:19167446 NCBI chr 2:166,226,736...166,255,978
Ensembl chr 2:166,226,754...166,255,302
JBrowse link
G B3gnt5 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of B3GNT5 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of B3GNT5 mRNA
Coumestrol results in decreased expression of B3GNT5 mRNA
CTD PMID:19167446 NCBI chr11:84,919,055...84,931,160
Ensembl chr11:84,919,066...84,931,160
JBrowse link
G Bace1 beta-secretase 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BACE1 mRNA CTD PMID:19167446 NCBI chr 8:50,140,092...50,162,388
Ensembl chr 8:50,139,997...50,162,361
JBrowse link
G Bace2 beta-secretase 2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BACE2 mRNA CTD PMID:19167446 NCBI chr11:37,798,397...37,880,624
Ensembl chr11:37,798,370...37,880,821
JBrowse link
G Bag2 BAG cochaperone 2 increases expression
multiple interactions
ISO Coumestrol results in increased expression of BAG2 mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of BAG2 mRNA
CTD PMID:19167446 NCBI chr 9:38,456,487...38,467,120
Ensembl chr 9:38,456,468...38,467,118
JBrowse link
G Bag3 BAG cochaperone 3 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BAG3 mRNA
Coumestrol results in decreased expression of BAG3 mRNA
CTD PMID:19167446 NCBI chr 1:199,941,258...199,965,191
Ensembl chr 1:199,941,161...199,965,191
JBrowse link
G Bag5 BAG cochaperone 5 decreases expression ISO Coumestrol results in decreased expression of BAG5 mRNA CTD PMID:19167446 NCBI chr 6:136,180,640...136,185,651
Ensembl chr 6:136,182,006...136,185,651
JBrowse link
G Banf1 BAF nuclear assembly factor 1 increases expression ISO Coumestrol results in increased expression of BANF1 mRNA CTD PMID:19167446 NCBI chr 1:220,744,195...220,746,224
Ensembl chr 1:220,744,195...220,746,224
JBrowse link
G Bard1 BRCA1 associated RING domain 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BARD1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of BARD1 mRNA
Coumestrol results in increased expression of BARD1 mRNA
CTD PMID:19167446 NCBI chr 9:78,297,723...78,368,777
Ensembl chr 9:78,294,834...78,369,031
JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases expression
affects binding
ISO Coumestrol results in increased expression of BAX protein
Coumestrol binds to BAX protein
CTD PMID:28986287 NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
JBrowse link
G Baz2a bromodomain adjacent to zinc finger domain, 2A decreases expression ISO Coumestrol results in decreased expression of BAZ2A mRNA CTD PMID:19167446 NCBI chr 7:2,518,267...2,548,840
Ensembl chr 7:2,529,077...2,547,062
JBrowse link
G Bbs1 Bardet-Biedl syndrome 1 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of BBS1 mRNA CTD PMID:19167446 NCBI chr 1:220,146,084...220,165,545
Ensembl chr 1:220,147,327...220,165,678
JBrowse link
G Bcas3 BCAS3, microtubule associated cell migration factor multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of BCAS3 mRNA CTD PMID:19167446 NCBI chr10:72,756,548...73,271,851 JBrowse link
G Bckdhb branched chain keto acid dehydrogenase E1 subunit beta decreases expression ISO Coumestrol results in decreased expression of BCKDHB mRNA CTD PMID:19167446 NCBI chr 8:91,464,229...91,656,134
Ensembl chr 8:91,464,229...91,656,134
JBrowse link
G Bcl2 BCL2, apoptosis regulator decreases expression
affects binding
multiple interactions
ISO Coumestrol results in decreased expression of BCL2 protein
Coumestrol binds to BCL2 protein
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BCL2 mRNA
CTD PMID:19167446, PMID:20623010, PMID:28986287 NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
JBrowse link
G Bcl2l12 BCL2 like 12 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BCL2L12 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of BCL2L12 mRNA
Coumestrol results in increased expression of BCL2L12 mRNA
CTD PMID:19167446 NCBI chr 1:100,984,550...100,993,269
Ensembl chr 1:100,984,550...100,993,269
JBrowse link
G Bcl3 BCL3, transcription coactivator multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BCL3 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of BCL3 mRNA CTD PMID:19167446 NCBI chr 1:80,730,758...80,745,273
Ensembl chr 1:80,730,499...80,744,831
JBrowse link
G Bcl9 BCL9, transcription coactivator multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BCL9 mRNA CTD PMID:19167446 NCBI chr 2:199,334,644...199,420,083
Ensembl chr 2:199,334,664...199,354,793
JBrowse link
G Bcl9l BCL9 like decreases expression ISO Coumestrol results in decreased expression of BCL9L mRNA CTD PMID:19167446 NCBI chr 8:48,805,684...48,835,794
Ensembl chr 8:48,805,684...48,834,312
JBrowse link
G Bclaf1 BCL2-associated transcription factor 1 increases expression ISO Coumestrol results in increased expression of BCLAF1 mRNA CTD PMID:19167446 NCBI chr 1:15,799,753...15,828,838
Ensembl chr 1:15,782,477...15,860,624
JBrowse link
G Bclaf3 BCLAF1 and THRAP3 family member 3 decreases expression ISO Coumestrol results in decreased expression of BCLAF3 mRNA CTD PMID:19167446 NCBI chr  X:38,294,009...38,353,525
Ensembl chr  X:38,295,365...38,353,461
JBrowse link
G Bcs1l BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone increases expression ISO Coumestrol results in increased expression of BCS1L mRNA CTD PMID:19167446 NCBI chr 9:81,868,158...81,872,201
Ensembl chr 9:81,868,265...81,872,197
JBrowse link
G Bex2 brain expressed X-linked 2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BEX2 mRNA CTD PMID:19167446 NCBI chr  X:106,556,838...106,558,366
Ensembl chr  X:106,556,838...106,558,366
JBrowse link
G Bhlhe40 basic helix-loop-helix family, member e40 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BHLHE40 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of BHLHE40 mRNA
Coumestrol results in decreased expression of BHLHE40 mRNA
CTD PMID:19167446 NCBI chr 4:140,703,619...140,709,319
Ensembl chr 4:140,703,619...140,709,319
JBrowse link
G Bik BCL2-interacting killer multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of BIK mRNA CTD PMID:19167446 NCBI chr 7:124,390,924...124,410,449
Ensembl chr 7:124,391,432...124,410,447
JBrowse link
G Bin3 bridging integrator 3 multiple interactions ISO [Coumestrol co-treated with ESR1 protein] results in increased expression of BIN3 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of BIN3 mRNA] CTD PMID:18310284 NCBI chr15:51,799,339...51,818,697
Ensembl chr15:51,779,839...51,818,699
JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BIRC5 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of BIRC5 mRNA
Coumestrol results in increased expression of BIRC5 mRNA
CTD PMID:19167446 NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
JBrowse link
G Blm BLM RecQ like helicase multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BLM mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of BLM mRNA
Coumestrol results in increased expression of BLM mRNA
CTD PMID:19167446 NCBI chr 1:142,246,773...142,332,616
Ensembl chr 1:142,246,790...142,332,588
JBrowse link
G Blnk B-cell linker multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BLNK mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of BLNK mRNA CTD PMID:19167446 NCBI chr 1:260,187,023...260,254,490
Ensembl chr 1:260,186,967...260,254,600
JBrowse link
G Bloc1s6 biogenesis of lysosomal organelles complex 1 subunit 6 decreases expression ISO Coumestrol results in decreased expression of BLOC1S6 mRNA CTD PMID:19167446 NCBI chr 3:114,869,478...114,880,218
Ensembl chr 3:114,869,459...114,881,590
JBrowse link
G Blvrb biliverdin reductase B increases expression ISO Coumestrol results in increased expression of BLVRB mRNA CTD PMID:19167446 NCBI chr 1:84,256,063...84,273,726
Ensembl chr 1:84,256,159...84,274,075
JBrowse link
G Blzf1 basic leucine zipper nuclear factor 1 decreases expression ISO Coumestrol results in decreased expression of BLZF1 mRNA CTD PMID:19167446 NCBI chr13:82,592,170...82,607,379
Ensembl chr13:82,592,170...82,607,379
JBrowse link
G Bmerb1 bMERB domain containing 1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BMERB1 mRNA; [Coumestrol co-treated with Resveratrol] results in decreased expression of BMERB1 mRNA
Coumestrol results in decreased expression of BMERB1 mRNA
CTD PMID:19167446 NCBI chr10:3,411,380...3,570,689
Ensembl chr10:3,411,380...3,570,688
JBrowse link
G Bmf Bcl2 modifying factor multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BMF mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of BMF mRNA
Coumestrol results in decreased expression of BMF mRNA
CTD PMID:19167446 NCBI chr 3:110,303,515...110,324,125
Ensembl chr 3:110,306,067...110,324,084
JBrowse link
G Bmp2 bone morphogenetic protein 2 multiple interactions ISO Coumestrol inhibits the reaction [menatetrenone promotes the reaction [Phosphates results in increased expression of BMP2 mRNA]]; Coumestrol inhibits the reaction [menatetrenone results in increased expression of BMP2 mRNA]; Coumestrol inhibits the reaction [menatetrenone results in increased susceptibility to BMP2 protein]; Coumestrol inhibits the reaction [Phosphates promotes the reaction [menatetrenone results in increased expression of BMP2 mRNA]] CTD PMID:31843813 NCBI chr 3:126,335,963...126,346,771
Ensembl chr 3:126,335,863...126,346,318
JBrowse link
G Bmp5 bone morphogenetic protein 5 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of BMP5 mRNA CTD PMID:19167446 NCBI chr 8:82,669,466...82,950,273
Ensembl chr 8:82,878,941...82,950,273
JBrowse link
G Bmp7 bone morphogenetic protein 7 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BMP7 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of BMP7 mRNA
Coumestrol results in decreased expression of BMP7 mRNA
CTD PMID:19167446 NCBI chr 3:170,879,972...170,955,820
Ensembl chr 3:170,879,973...170,955,399
JBrowse link
G Bmpr2 bone morphogenetic protein receptor type 2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BMPR2 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of BMPR2 mRNA CTD PMID:19167446 NCBI chr 9:66,568,074...66,683,019
Ensembl chr 9:66,568,074...66,676,494
JBrowse link
G Bnip3l BCL2 interacting protein 3 like decreases expression ISO Coumestrol results in decreased expression of BNIP3L mRNA CTD PMID:19167446 NCBI chr15:43,643,897...43,667,123
Ensembl chr15:43,643,897...43,667,029
JBrowse link
G Bora bora, aurora kinase A activator increases expression
multiple interactions
ISO Coumestrol results in increased expression of BORA mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of BORA mRNA
CTD PMID:19167446 NCBI chr15:83,442,217...83,463,737
Ensembl chr15:83,442,144...83,463,717
JBrowse link
G Brat1 BRCA1-associated ATM activator 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRAT1 mRNA CTD PMID:19167446 NCBI chr12:16,016,062...16,028,534
Ensembl chr12:16,015,771...16,027,881
JBrowse link
G Brca1 BRCA1, DNA repair associated multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRCA1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of BRCA1 mRNA
Coumestrol results in increased expression of BRCA1 mRNA
CTD PMID:19167446 NCBI chr10:89,394,821...89,455,093
Ensembl chr10:89,394,803...89,454,681
JBrowse link
G Brca2 BRCA2, DNA repair associated multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRCA2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of BRCA2 mRNA
Coumestrol results in increased expression of BRCA2 mRNA
CTD PMID:19167446 NCBI chr12:503,660...544,754
Ensembl chr12:504,007...544,748
JBrowse link
G Brd3 bromodomain containing 3 decreases expression ISO Coumestrol results in decreased expression of BRD3 mRNA CTD PMID:19167446 NCBI chr 3:5,995,204...6,054,467
Ensembl chr 3:5,997,315...6,054,483
JBrowse link
G Bri3 brain protein I3 decreases expression ISO Coumestrol results in decreased expression of BRI3 mRNA CTD PMID:19167446 NCBI chr12:12,322,247...12,330,929
Ensembl chr12:12,322,243...12,330,939
JBrowse link
G Bri3bp Bri3 binding protein multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRI3BP mRNA CTD PMID:19167446 NCBI chr12:36,576,018...36,587,839
Ensembl chr12:36,576,020...36,587,839
JBrowse link
G Brwd1 bromodomain and WD repeat domain containing 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BRWD1 mRNA CTD PMID:19167446 NCBI chr11:36,338,080...36,430,473
Ensembl chr11:36,337,635...36,430,413
JBrowse link
G Bsdc1 BSD domain containing 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BSDC1 mRNA CTD PMID:19167446 NCBI chr 5:147,661,618...147,689,766
Ensembl chr 5:147,661,618...147,689,759
JBrowse link
G Bsg basigin (Ok blood group) multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BSG mRNA CTD PMID:19167446 NCBI chr 7:12,875,536...12,882,753
Ensembl chr 7:12,875,537...12,882,753
JBrowse link
G Btbd7 BTB domain containing 7 decreases expression ISO Coumestrol results in decreased expression of BTBD7 mRNA CTD PMID:19167446 NCBI chr 6:126,658,398...126,748,497
Ensembl chr 6:126,661,634...126,710,858
JBrowse link
G Btg1 BTG anti-proliferation factor 1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BTG1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of BTG1 mRNA
Coumestrol results in decreased expression of BTG1 mRNA
CTD PMID:19167446 NCBI chr 7:37,812,831...37,815,088
Ensembl chr 7:37,812,831...37,815,088
JBrowse link
G Btg2 BTG anti-proliferation factor 2 multiple interactions
decreases expression
ISO [Coumestrol co-treated with resveratrol] results in decreased expression of BTG2 mRNA
Coumestrol results in decreased expression of BTG2 mRNA
CTD PMID:19167446 NCBI chr13:50,913,185...50,916,944
Ensembl chr13:50,913,180...50,916,982
JBrowse link
G Bub1 BUB1 mitotic checkpoint serine/threonine kinase increases expression
multiple interactions
ISO Coumestrol results in increased expression of BUB1 mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of BUB1 mRNA
CTD PMID:19167446 NCBI chr 3:120,373,604...120,404,910
Ensembl chr 3:120,373,604...120,404,910
JBrowse link
G Bub1b BUB1 mitotic checkpoint serine/threonine kinase B multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BUB1B mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of BUB1B mRNA
Coumestrol results in increased expression of BUB1B mRNA
CTD PMID:19167446 NCBI chr 3:110,367,949...110,420,471
Ensembl chr 3:110,367,939...110,420,458
JBrowse link
G C1H9orf66 chromosome 1 open reading frame, human C9orf66 decreases expression ISO Coumestrol results in decreased expression of DOCK8-AS1 mRNA CTD PMID:19167446 NCBI chr 1:242,958,912...242,961,750 JBrowse link
G C5 complement C5 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of C5 mRNA CTD PMID:19167446 NCBI chr 3:14,049,993...14,113,931
NCBI chr 3:14,206,466...14,229,141
Ensembl chr 3:14,049,995...14,229,080
JBrowse link
G Ca12 carbonic anhydrase 12 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CA12 mRNA CTD PMID:19167446 NCBI chr 8:72,405,770...72,461,425
Ensembl chr 8:72,405,748...72,460,240
JBrowse link
G Cacybp calcyclin binding protein increases expression
multiple interactions
ISO Coumestrol results in increased expression of CACYBP mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of CACYBP mRNA
CTD PMID:19167446 NCBI chr13:77,948,771...77,959,089
Ensembl chr13:77,948,771...77,959,110
JBrowse link
G Cadm1 cell adhesion molecule 1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CADM1 mRNA
Coumestrol results in decreased expression of CADM1 mRNA
CTD PMID:19167446 NCBI chr 8:51,858,906...52,200,591
Ensembl chr 8:52,127,399...52,189,722
JBrowse link
G Calcr calcitonin receptor multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CALCR mRNA CTD PMID:19167446 NCBI chr 4:28,627,439...28,702,559
Ensembl chr 4:28,627,442...28,702,559
JBrowse link
G Calm3 calmodulin 3 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CALM3 mRNA CTD PMID:19167446 NCBI chr 1:78,844,520...78,851,628
Ensembl chr 1:78,843,080...78,851,719
JBrowse link
G Calu calumenin multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CALU mRNA
Coumestrol results in increased expression of CALU mRNA
CTD PMID:19167446 NCBI chr 4:56,625,611...56,653,112
Ensembl chr 4:56,625,561...56,653,111
JBrowse link
G Camk1d calcium/calmodulin-dependent protein kinase ID decreases expression ISO Coumestrol results in decreased expression of CAMK1D mRNA CTD PMID:19167446 NCBI chr17:76,532,611...76,938,956
Ensembl chr17:76,532,611...76,938,956
JBrowse link
G Camk2d calcium/calmodulin-dependent protein kinase II delta decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of CAMK2D mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CAMK2D mRNA
CTD PMID:19167446 NCBI chr 2:230,900,907...231,132,207
Ensembl chr 2:230,901,126...231,132,039
JBrowse link
G Camk2n1 calcium/calmodulin-dependent protein kinase II inhibitor 1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CAMK2N1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of CAMK2N1 mRNA
Coumestrol results in decreased expression of CAMK2N1 mRNA
CTD PMID:19167446 NCBI chr 5:156,876,706...156,878,486
Ensembl chr 5:156,876,706...156,878,486
JBrowse link
G Cant1 calcium activated nucleotidase 1 increases expression ISO Coumestrol results in increased expression of CANT1 mRNA CTD PMID:19167446 NCBI chr10:107,432,500...107,445,634
Ensembl chr10:107,432,506...107,445,522
JBrowse link
G Car2 carbonic anhydrase 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CA2 mRNA CTD PMID:19167446 NCBI chr 2:88,097,740...88,112,868
Ensembl chr 2:88,097,720...88,113,029
JBrowse link
G Carhsp1 calcium regulated heat stable protein 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CARHSP1 mRNA
Coumestrol results in increased expression of CARHSP1 mRNA
CTD PMID:19167446 NCBI chr10:7,041,510...7,055,107
Ensembl chr10:7,041,510...7,055,101
JBrowse link
G Casp3 caspase 3 increases expression EXP
ISO
Coumestrol results in increased expression of CASP3 protein CTD PMID:19165469, PMID:28986287 NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
JBrowse link
G Casp7 caspase 7 increases expression EXP Coumestrol results in increased expression of CASP7 protein CTD PMID:19165469 NCBI chr 1:277,190,557...277,242,779
Ensembl chr 1:277,190,964...277,242,774
JBrowse link
G Casp8ap2 caspase 8 associated protein 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CASP8AP2 mRNA CTD PMID:19167446 NCBI chr 5:47,853,699...47,891,147
Ensembl chr 5:47,853,818...47,891,668
JBrowse link
G Casp9 caspase 9 increases expression ISO Coumestrol results in increased expression of CASP9 protein CTD PMID:28986287 NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
JBrowse link
G Cast calpastatin multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CAST mRNA CTD PMID:19167446 NCBI chr 2:1,452,111...1,561,669
Ensembl chr 2:1,452,116...1,561,464
JBrowse link
G Cav1 caveolin 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with resveratrol] results in increased expression of CAV1 mRNA
Coumestrol results in increased expression of CAV1 mRNA
CTD PMID:19167446 NCBI chr 4:44,597,123...44,630,206
Ensembl chr 4:44,597,123...44,630,200
JBrowse link
G Cbfb core-binding factor subunit beta multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CBFB mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CBFB mRNA
Coumestrol results in increased expression of CBFB mRNA
CTD PMID:19167446 NCBI chr19:37,127,508...37,171,075
Ensembl chr19:37,127,508...37,171,069
JBrowse link
G Cblb Cbl proto-oncogene B decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of CBLB mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CBLB mRNA
CTD PMID:19167446 NCBI chr11:51,037,383...51,202,761
Ensembl chr11:51,037,393...51,202,820
JBrowse link
G Cbr1 carbonyl reductase 1 increases expression ISO Coumestrol results in increased expression of CBR1 mRNA CTD PMID:19167446 NCBI chr11:33,813,041...33,815,418
Ensembl chr11:33,845,463...33,847,793
JBrowse link
G Cbx4 chromobox 4 decreases expression ISO Coumestrol results in decreased expression of CBX4 mRNA CTD PMID:19167446 NCBI chr10:108,190,947...108,196,455
Ensembl chr10:108,190,995...108,196,217
JBrowse link
G Cbx5 chromobox 5 multiple interactions
increases expression
ISO [Coumestrol co-treated with resveratrol] results in increased expression of CBX5 mRNA
Coumestrol results in increased expression of CBX5 mRNA
CTD PMID:19167446 NCBI chr 7:144,819,673...144,865,014
Ensembl chr 7:144,819,420...144,837,583
JBrowse link
G Ccdc117 coiled-coil domain containing 117 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CCDC117 mRNA CTD PMID:19167446 NCBI chr14:85,763,396...85,772,762
Ensembl chr14:85,763,397...85,772,762
JBrowse link
G Ccdc14 coiled-coil domain containing 14 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCDC14 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CCDC14 mRNA CTD PMID:19167446 NCBI chr11:69,281,000...69,316,897
Ensembl chr11:69,281,554...69,316,848
JBrowse link
G Ccdc167 coiled-coil domain containing 167 increases expression ISO Coumestrol results in increased expression of CCDC167 mRNA CTD PMID:19167446 NCBI chr20:8,367,047...8,384,119
Ensembl chr20:8,369,331...8,384,088
JBrowse link
G Ccdc34 coiled-coil domain containing 34 increases expression
multiple interactions
ISO Coumestrol results in increased expression of CCDC34 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCDC34 mRNA
CTD PMID:19167446 NCBI chr 3:101,156,212...101,191,363
Ensembl chr 3:101,156,212...101,191,363
JBrowse link
G Ccdc47 coiled-coil domain containing 47 increases expression ISO Coumestrol results in increased expression of CCDC47 mRNA CTD PMID:19167446 NCBI chr10:94,388,425...94,406,949
Ensembl chr10:94,388,430...94,406,949
JBrowse link
G Ccdc51 coiled-coil domain containing 51 increases expression ISO Coumestrol results in increased expression of CCDC51 mRNA CTD PMID:19167446 NCBI chr 8:117,812,091...117,830,848
Ensembl chr 8:117,812,099...117,830,868
JBrowse link
G Ccdc88c coiled-coil domain containing 88C decreases expression ISO Coumestrol results in decreased expression of CCDC88C mRNA CTD PMID:19167446 NCBI chr 6:124,905,811...125,028,011
Ensembl chr 6:124,905,808...125,027,553
JBrowse link
G Ccn1 cellular communication network factor 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CCN1 mRNA CTD PMID:19167446 NCBI chr 2:251,529,354...251,532,312
Ensembl chr 2:251,529,354...251,532,312
JBrowse link
G Ccn5 cellular communication network factor 5 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCN5 mRNA; [Coumestrol co-treated with Resveratrol] results in increased expression of CCN5 mRNA; ESR1 protein inhibits the reaction [Coumestrol results in increased expression of CCN5 mRNA] CTD PMID:19167446, PMID:23384675 NCBI chr 3:160,207,969...160,219,316
Ensembl chr 3:160,207,913...160,219,331
JBrowse link
G Ccna2 cyclin A2 decreases expression
increases expression
multiple interactions
ISO Coumestrol results in decreased expression of CCNA2 protein
Coumestrol results in increased expression of CCNA2 protein
[Coumestrol co-treated with ESR1 protein] results in increased expression of CCNA2 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CCNA2 mRNA]
CTD PMID:18310284, PMID:20623010 NCBI chr 2:123,274,727...123,282,266
Ensembl chr 2:123,275,881...123,282,214
JBrowse link
G Ccnb1 cyclin B1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNB1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CCNB1 mRNA
Coumestrol results in increased expression of CCNB1 mRNA
CTD PMID:19167446 NCBI chr 2:30,782,133...30,791,106
Ensembl chr 2:30,783,915...30,791,221
JBrowse link
G Ccnb2 cyclin B2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNB2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CCNB2 mRNA
Coumestrol results in increased expression of CCNB2 mRNA
CTD PMID:19167446 NCBI chr 8:76,847,972...76,861,165 JBrowse link
G Ccnd1 cyclin D1 multiple interactions
increases expression
ISO CCND1 protein promotes the reaction [Coumestrol results in increased activity of ESR1 protein]
Coumestrol results in increased expression of CCND1 mRNA
CTD PMID:16328721, PMID:19800779 NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
JBrowse link
G Ccne1 cyclin E1 decreases expression ISO Coumestrol results in decreased expression of CCNE1 protein CTD PMID:28986287 NCBI chr 1:94,485,830...94,495,112
Ensembl chr 1:94,485,832...94,494,980
JBrowse link
G Ccne2 cyclin E2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNE2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CCNE2 mRNA
Coumestrol results in increased expression of CCNE2 mRNA
CTD PMID:19167446 NCBI chr 5:24,434,077...24,446,406
Ensembl chr 5:24,434,872...24,446,406
JBrowse link
G Ccnf cyclin F multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNF mRNA
Coumestrol results in increased expression of CCNF mRNA
CTD PMID:19167446 NCBI chr10:13,594,687...13,619,935
Ensembl chr10:13,594,687...13,619,935
JBrowse link
G Ccng2 cyclin G2 decreases expression ISO Coumestrol results in decreased expression of CCNG2 mRNA CTD PMID:19167446 NCBI chr14:16,267,572...16,276,068
Ensembl chr14:16,267,573...16,276,068
JBrowse link
G Ccni cyclin I decreases expression ISO Coumestrol results in decreased expression of CCNI mRNA CTD PMID:19167446 NCBI chr14:16,341,510...16,364,326
Ensembl chr14:16,341,536...16,364,326
JBrowse link
G Ccp110 centriolar coiled-coil protein 110 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CP110 mRNA CTD PMID:19167446 NCBI chr 1:188,417,012...188,444,991
Ensembl chr 1:188,420,461...188,444,991
JBrowse link
G Ccpg1 cell cycle progression 1 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of CCPG1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CCPG1 mRNA
CTD PMID:19167446 NCBI chr 8:79,660,634...79,692,044
Ensembl chr 8:79,660,657...79,692,039
JBrowse link
G Cd24 CD24 molecule multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of CD24 mRNA CTD PMID:19167446 NCBI chr20:48,335,540...48,340,847
Ensembl chr20:48,335,540...48,340,846
JBrowse link
G Cd320 CD320 molecule increases expression ISO Coumestrol results in increased expression of CD320 mRNA CTD PMID:19167446 NCBI chr 7:18,700,445...18,706,244
Ensembl chr 7:18,700,344...18,706,244
JBrowse link
G Cd44 CD44 molecule (Indian blood group) multiple interactions
increases expression
ISO [Coumestrol co-treated with resveratrol] results in increased expression of CD44 mRNA
Coumestrol results in increased expression of CD44 mRNA
CTD PMID:19167446 NCBI chr 3:92,695,083...92,783,820
Ensembl chr 3:92,696,313...92,783,658
JBrowse link
G Cd55 CD55 molecule (Cromer blood group) decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of CD55 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CD55 mRNA
CTD PMID:19167446 NCBI chr13:47,125,156...47,153,557
Ensembl chr13:47,126,741...47,154,292
JBrowse link
G Cd59 CD59 molecule multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CD59 mRNA CTD PMID:19167446 NCBI chr 3:94,010,481...94,028,660
Ensembl chr 3:94,010,475...94,028,621
JBrowse link
G Cdc14b cell division cycle 14B decreases expression ISO Coumestrol results in decreased expression of CDC14B mRNA CTD PMID:19167446 NCBI chr17:1,709,703...1,797,732
Ensembl chr17:1,703,943...1,797,750
JBrowse link
G Cdc25a cell division cycle 25A increases expression
multiple interactions
ISO Coumestrol results in increased expression of CDC25A mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC25A mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDC25A mRNA
CTD PMID:19167446 NCBI chr 8:117,953,223...117,971,552
Ensembl chr 8:117,953,444...117,971,519
JBrowse link
G Cdc25c cell division cycle 25C increases expression
multiple interactions
ISO Coumestrol results in increased expression of CDC25C mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC25C mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDC25C mRNA
CTD PMID:19167446 NCBI chr18:27,528,768...27,550,316
Ensembl chr18:27,528,354...27,550,224
JBrowse link
G Cdc27 cell division cycle 27 increases expression
multiple interactions
ISO Coumestrol results in increased expression of CDC27 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC27 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDC27 mRNA
CTD PMID:19167446 NCBI chr10:92,551,754...92,602,214
Ensembl chr10:92,554,081...92,602,082
JBrowse link
G Cdc42bpb CDC42 binding protein kinase beta decreases expression ISO Coumestrol results in decreased expression of CDC42BPB mRNA CTD PMID:19167446 NCBI chr 6:135,746,743...135,830,144
Ensembl chr 6:135,746,754...135,830,086
JBrowse link
G Cdc45 cell division cycle 45 increases expression
multiple interactions
ISO Coumestrol results in increased expression of CDC45 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC45 mRNA; [Coumestrol co-treated with Resveratrol] results in increased expression of CDC45 mRNA
CTD PMID:19167446 NCBI chr11:86,328,785...86,354,099
Ensembl chr11:86,329,012...86,358,453
JBrowse link
G Cdc5l cell division cycle 5-like increases expression ISO Coumestrol results in increased expression of CDC5L mRNA CTD PMID:19167446 NCBI chr 9:17,949,764...17,988,514
Ensembl chr 9:17,949,764...17,988,509
JBrowse link
G Cdc6 cell division cycle 6 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC6 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDC6 mRNA
Coumestrol results in increased expression of CDC6 mRNA
CTD PMID:19167446 NCBI chr10:86,819,477...86,833,301
Ensembl chr10:86,819,472...86,833,402
JBrowse link
G Cdc7 cell division cycle 7 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC7 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDC7 mRNA
Coumestrol results in increased expression of CDC7 mRNA
CTD PMID:19167446 NCBI chr14:3,826,658...3,846,891
Ensembl chr14:3,826,659...3,846,891
JBrowse link
G Cdca2 cell division cycle associated 2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDCA2 mRNA
Coumestrol results in increased expression of CDCA2 mRNA
CTD PMID:19167446 NCBI chr15:44,365,396...44,411,601
Ensembl chr15:44,365,405...44,411,004
JBrowse link
G Cdca3 cell division cycle associated 3 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA3 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of CDCA3 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDCA3 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CDCA3 mRNA]
Coumestrol results in increased expression of CDCA3 mRNA
CTD PMID:18310284, PMID:19167446 NCBI chr 4:157,347,876...157,351,889
Ensembl chr 4:157,348,020...157,351,604
JBrowse link
G Cdca4 cell division cycle associated 4 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA4 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDCA4 mRNA CTD PMID:19167446 NCBI chr 6:137,396,133...137,421,283
Ensembl chr 6:137,396,140...137,421,283
JBrowse link
G Cdca5 cell division cycle associated 5 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA5 mRNA; [Coumestrol co-treated with Resveratrol] results in increased expression of CDCA5 mRNA
Coumestrol results in increased expression of CDCA5 mRNA
CTD PMID:19167446 NCBI chr 1:221,448,661...221,462,235
Ensembl chr 1:221,448,661...221,462,233
JBrowse link
G Cdca7l cell division cycle associated 7 like multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA7L mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDCA7L mRNA
Coumestrol results in increased expression of CDCA7L mRNA
CTD PMID:19167446 NCBI chr 6:145,739,570...145,785,607
Ensembl chr 6:145,740,035...145,785,606
JBrowse link
G Cdca8 cell division cycle associated 8 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA8 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDCA8 mRNA
Coumestrol results in increased expression of CDCA8 mRNA
CTD PMID:19167446 NCBI chr 5:142,911,310...142,933,536
Ensembl chr 5:142,911,305...142,933,526
JBrowse link
G Cdh12 cadherin 12 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDH12 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDH12 mRNA CTD PMID:19167446 NCBI chr 2:71,310,228...72,540,063
Ensembl chr 2:72,006,099...72,540,263
JBrowse link
G Cdk1 cyclin-dependent kinase 1 increases expression
multiple interactions
ISO Coumestrol results in increased expression of CDK1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDK1 mRNA; [Coumestrol co-treated with Resveratrol] results in increased expression of CDK1 mRNA
CTD PMID:19167446 NCBI chr20:20,576,341...20,591,510
Ensembl chr20:20,576,377...20,591,549
JBrowse link
G Cdk13 cyclin-dependent kinase 13 decreases expression ISO Coumestrol results in decreased expression of CDK13 mRNA CTD PMID:19167446 NCBI chr17:49,833,194...49,922,932
Ensembl chr17:49,833,400...49,921,550
JBrowse link
G Cdk17 cyclin-dependent kinase 17 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PCTK2 mRNA CTD PMID:19167446 NCBI chr 7:34,001,506...34,088,418
Ensembl chr 7:34,001,506...34,079,616
JBrowse link
G Cdk2 cyclin dependent kinase 2 decreases expression ISO Coumestrol results in decreased expression of CDK2 protein CTD PMID:28986287 NCBI chr 7:3,124,953...3,132,533
Ensembl chr 7:3,124,954...3,132,457
JBrowse link
G Cdk2ap2 cyclin-dependent kinase 2 associated protein 2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDK2AP2 mRNA CTD PMID:19167446 NCBI chr 1:219,345,638...219,347,709
Ensembl chr 1:219,345,918...219,347,728
JBrowse link
G Cdk5rap2 CDK5 regulatory subunit associated protein 2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDK5RAP2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDK5RAP2 mRNA
Coumestrol results in increased expression of CDK5RAP2 mRNA
CTD PMID:19167446 NCBI chr 5:86,387,238...86,554,108
Ensembl chr 5:86,387,078...86,554,102
JBrowse link
G Cdkl5 cyclin-dependent kinase-like 5 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of CDKL5 mRNA CTD PMID:19167446 NCBI chr  X:35,536,396...35,773,204
Ensembl chr  X:35,599,258...35,771,711
JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of CDKN1A mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CDKN1A mRNA
CTD PMID:19167446 NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
JBrowse link
G Cdkn1c cyclin-dependent kinase inhibitor 1C decreases expression ISO Coumestrol results in decreased expression of CDKN1C mRNA CTD PMID:19167446 NCBI chr 1:216,661,067...216,663,791
Ensembl chr 1:216,661,080...216,663,721
JBrowse link
G Cdkn2aip CDKN2A interacting protein decreases expression ISO Coumestrol results in decreased expression of CDKN2AIP mRNA CTD PMID:19167446 NCBI chr16:47,664,864...47,670,935
Ensembl chr16:47,665,816...47,669,093
JBrowse link
G Cdkn2b cyclin-dependent kinase inhibitor 2B multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CDKN2B mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of CDKN2B mRNA
Coumestrol results in decreased expression of CDKN2B mRNA
CTD PMID:19167446 NCBI chr 5:107,834,353...107,857,428
Ensembl chr 5:107,845,951...107,858,104
JBrowse link
G Cdkn2c cyclin-dependent kinase inhibitor 2C multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDKN2C mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of CDKN2C mRNA; ESR2 protein promotes the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CDKN2C mRNA]
Coumestrol results in increased expression of CDKN2C mRNA
CTD PMID:18310284, PMID:19167446 NCBI chr 5:129,347,731...129,352,886
Ensembl chr 5:129,347,732...129,352,886
JBrowse link
G Cdkn3 cyclin-dependent kinase inhibitor 3 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDKN3 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of CDKN3 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDKN3 mRNA; ESR2 protein promotes the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CDKN3 mRNA]
Coumestrol results in increased expression of CDKN3 mRNA
CTD PMID:18310284, PMID:19167446 NCBI chr15:23,553,171...23,564,538
Ensembl chr15:23,553,128...23,564,535
JBrowse link
G Cds1 CDP-diacylglycerol synthase 1 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of CDS1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CDS1 mRNA
CTD PMID:19167446 NCBI chr14:9,396,511...9,456,964
Ensembl chr14:9,396,512...9,456,990
JBrowse link
G Cdt1 chromatin licensing and DNA replication factor 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDT1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDT1 mRNA
Coumestrol results in increased expression of CDT1 mRNA
CTD PMID:19167446 NCBI chr19:55,381,565...55,386,511
Ensembl chr19:55,381,565...55,386,511
JBrowse link
G Cdv3 CDV3 homolog increases expression
multiple interactions
ISO Coumestrol results in increased expression of CDV3 mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of CDV3 mRNA
CTD PMID:19167446 NCBI chr 8:111,837,232...111,850,393
Ensembl chr 8:111,839,091...111,850,393
JBrowse link
G Cdyl chromodomain Y-like decreases expression ISO Coumestrol results in decreased expression of CDYL mRNA CTD PMID:19167446 NCBI chr17:29,672,925...29,895,416
Ensembl chr17:29,674,164...29,895,386
JBrowse link
G Cebpd CCAAT/enhancer binding protein delta multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CEBPD mRNA CTD PMID:19167446 NCBI chr11:89,008,008...89,009,146
Ensembl chr11:89,008,008...89,009,146
JBrowse link
G Celsr2 cadherin, EGF LAG seven-pass G-type receptor 2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CELSR2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CELSR2 mRNA
Coumestrol results in increased expression of CELSR2 mRNA
CTD PMID:19167446 NCBI chr 2:211,183,410...211,207,458
Ensembl chr 2:211,183,311...211,207,465
JBrowse link
G Cenpa centromere protein A multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPA mRNA; [Coumestrol co-treated with Resveratrol] results in increased expression of CENPA mRNA
Coumestrol results in increased expression of CENPA mRNA
CTD PMID:19167446 NCBI chr 6:27,072,259...27,080,863
Ensembl chr 6:27,072,166...27,080,856
JBrowse link
G Cenpe centromere protein E increases expression
multiple interactions
ISO Coumestrol results in increased expression of CENPE mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of CENPE mRNA
CTD PMID:19167446 NCBI chr 2:240,395,974...240,454,785
Ensembl chr 2:240,396,152...240,454,747
JBrowse link
G Cenpf centromere protein F multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPF mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of CENPF mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CENPF mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CENPF mRNA]
Coumestrol results in increased expression of CENPF mRNA
CTD PMID:18310284, PMID:19167446 NCBI chr13:108,132,499...108,178,609
Ensembl chr13:108,132,499...108,178,609
JBrowse link
G Cenph centromere protein H increases expression
multiple interactions
ISO Coumestrol results in increased expression of CENPH mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPH mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CENPH mRNA
CTD PMID:19167446 NCBI chr 2:30,766,637...30,780,123
Ensembl chr 2:30,766,590...30,780,121
JBrowse link
G Cenpi centromere protein I increases expression
multiple interactions
ISO Coumestrol results in increased expression of CENPI mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPI mRNA
CTD PMID:19167446 NCBI chr  X:105,147,045...105,198,798
Ensembl chr  X:105,147,153...105,198,797
JBrowse link
G Cenpj centromere protein J increases expression ISO Coumestrol results in increased expression of CENPJ mRNA CTD PMID:19167446 NCBI chr15:36,745,672...36,809,228
Ensembl chr15:36,746,088...36,798,814
JBrowse link
G Cenpl centromere protein L increases expression
multiple interactions
ISO Coumestrol results in increased expression of CENPL mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPL mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CENPL mRNA
CTD PMID:19167446 NCBI chr13:78,886,092...78,901,025
Ensembl chr13:78,886,163...78,901,420
JBrowse link
G Cenpm centromere protein M multiple interactions
increases expression
ISO [Coumestrol co-treated with resveratrol] results in increased expression of CENPM mRNA
Coumestrol results in increased expression of CENPM mRNA
CTD PMID:19167446 NCBI chr 7:123,464,615...123,476,336
Ensembl chr 7:123,464,490...123,476,238
JBrowse link
G Cenpn centromere protein N multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPN mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CENPN mRNA
Coumestrol results in increased expression of CENPN mRNA
CTD PMID:19167446 NCBI chr19:49,457,461...49,479,989
Ensembl chr19:49,340,184...49,479,996
JBrowse link
G Cenpo centromere protein O multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPO mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CENPO mRNA
Coumestrol results in increased expression of CENPO mRNA
CTD PMID:19167446 NCBI chr 6:28,648,804...28,663,527
Ensembl chr 6:28,649,638...28,663,233
JBrowse link
G Cenpq centromere protein Q multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPQ mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CENPQ mRNA
Coumestrol results in increased expression of CENPQ mRNA
CTD PMID:19167446 NCBI chr 9:23,352,271...23,368,774 JBrowse link
G Cenps centromere protein S multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPS mRNA; [Coumestrol co-treated with Resveratrol] results in increased expression of CENPS mRNA
Coumestrol results in increased expression of CENPS mRNA
CTD PMID:19167446 NCBI chr 5:165,946,106...165,955,723 JBrowse link
G Cenpu centromere protein U multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPU mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CENPU mRNA
Coumestrol results in increased expression of CENPU mRNA
CTD PMID:19167446 NCBI chr16:48,898,032...48,921,248
Ensembl chr16:48,897,982...48,921,242
JBrowse link
G Cenpw centromere protein W multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPW mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CENPW mRNA
Coumestrol results in increased expression of CENPW mRNA
CTD PMID:19167446 NCBI chr 1:29,915,443...29,920,598
Ensembl chr 1:29,915,443...29,920,598
JBrowse link
G Cep128 centrosomal protein 128 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CEP128 mRNA CTD PMID:19167446 NCBI chr 6:114,759,474...115,158,004
Ensembl chr 6:114,759,474...115,157,854
JBrowse link
G Cep152 centrosomal protein 152 multiple interactions
increases expression
ISO [Coumestrol co-treated with resveratrol] results in increased expression of CEP152 mRNA
Coumestrol results in increased expression of CEP152 mRNA
CTD PMID:19167446 NCBI chr 3:117,822,799...117,894,856 JBrowse link
G Cep192 centrosomal protein 192 increases expression ISO Coumestrol results in increased expression of CEP192 mRNA CTD PMID:19167446 NCBI chr18:63,572,084...63,656,302
Ensembl chr18:63,524,452...63,656,286
JBrowse link
G Cep55 centrosomal protein 55 increases expression
multiple interactions
ISO Coumestrol results in increased expression of CEP55 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CEP55 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CEP55 mRNA
CTD PMID:19167446 NCBI chr 1:256,745,251...256,760,794
Ensembl chr 1:256,745,288...256,760,796
JBrowse link
G Cep57 centrosomal protein 57 multiple interactions
increases expression
ISO [Coumestrol co-treated with resveratrol] results in increased expression of CEP57 mRNA
Coumestrol results in increased expression of CEP57 mRNA
CTD PMID:19167446 NCBI chr 8:12,335,430...12,355,425
Ensembl chr 8:12,335,432...12,355,091
JBrowse link
G Cep57l1 centrosomal protein 57-like 1 increases expression ISO Coumestrol results in increased expression of CEP57L1 mRNA CTD PMID:19167446 NCBI chr20:46,610,144...46,666,780
Ensembl chr20:46,610,146...46,666,830
JBrowse link
G Cep78 centrosomal protein 78 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CEP78 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CEP78 mRNA
Coumestrol results in increased expression of CEP78 mRNA
CTD PMID:19167446 NCBI chr 1:233,185,815...233,214,876
Ensembl chr 1:233,186,989...233,214,758
JBrowse link
G Cep85 centrosomal protein 85 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CEP85 mRNA
Coumestrol results in increased expression of CEP85 mRNA
CTD PMID:19167446 NCBI chr 5:152,359,693...152,406,530
Ensembl chr 5:152,359,700...152,406,518
JBrowse link
G Cfap20 cilia and flagella associated protein 20 increases expression ISO Coumestrol results in increased expression of CFAP20 mRNA CTD PMID:19167446 NCBI chr19:10,024,938...10,038,838
Ensembl chr19:10,024,947...10,038,784
JBrowse link
G Cflar CASP8 and FADD-like apoptosis regulator decreases expression ISO Coumestrol results in decreased expression of CFLAR mRNA CTD PMID:19167446 NCBI chr 9:65,534,608...65,586,395
Ensembl chr 9:65,534,704...65,587,251
JBrowse link
G Cgn cingulin decreases expression ISO Coumestrol results in decreased expression of CGN mRNA CTD PMID:19167446 NCBI chr 2:195,909,691...195,937,130
Ensembl chr 2:195,909,626...195,935,878
JBrowse link
G Chac2 ChaC glutathione specific gamma-glutamylcyclotransferase 2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHAC2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CHAC2 mRNA
Coumestrol results in increased expression of CHAC2 mRNA
CTD PMID:19167446 NCBI chr14:115,383,906...115,391,757
Ensembl chr14:115,383,910...115,391,652
JBrowse link
G Chaf1a chromatin assembly factor 1 subunit A multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHAF1A mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CHAF1A mRNA
Coumestrol results in increased expression of CHAF1A mRNA
CTD PMID:19167446 NCBI chr 9:11,000,869...11,027,631
Ensembl chr 9:11,001,129...11,027,506
JBrowse link
G Chaf1b chromatin assembly factor 1 subunit B multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHAF1B mRNA
Coumestrol results in increased expression of CHAF1B mRNA
CTD PMID:19167446 NCBI chr11:34,101,248...34,121,371
Ensembl chr11:34,101,197...34,121,378
JBrowse link
G Chd2 chromodomain helicase DNA binding protein 2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CHD2 mRNA CTD PMID:19167446 NCBI chr 1:134,757,934...134,873,053
Ensembl chr 1:134,757,934...134,871,167
JBrowse link
G Chd6 chromodomain helicase DNA binding protein 6 decreases expression ISO Coumestrol results in decreased expression of CHD6 mRNA CTD PMID:19167446 NCBI chr 3:156,937,746...157,099,328
Ensembl chr 3:156,937,733...157,099,306
JBrowse link
G Chek1 checkpoint kinase 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHEK1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CHEK1 mRNA
Coumestrol results in increased expression of CHEK1 mRNA
CTD PMID:19167446 NCBI chr 8:39,181,162...39,201,588
Ensembl chr 8:39,181,163...39,243,882
JBrowse link
G Chek2 checkpoint kinase 2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHEK2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CHEK2 mRNA CTD PMID:19167446 NCBI chr12:51,845,574...51,878,098
Ensembl chr12:51,845,796...51,877,624
JBrowse link
G Chn1 chimerin 1 increases expression ISO Coumestrol results in increased expression of CHN1 mRNA CTD PMID:19167446 NCBI chr 3:60,512,360...60,668,413
Ensembl chr 3:60,513,077...60,611,924
JBrowse link
G Chpt1 choline phosphotransferase 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHPT1 mRNA CTD PMID:19167446 NCBI chr 7:29,019,518...29,070,928
Ensembl chr 7:29,043,916...29,070,928
JBrowse link
G Chrna5 cholinergic receptor nicotinic alpha 5 subunit increases expression ISO Coumestrol results in increased expression of CHRNA5 mRNA CTD PMID:19167446 NCBI chr 8:59,561,817...59,590,172
Ensembl chr 8:59,561,721...59,590,172
JBrowse link
G Cip2a cellular inhibitor of PP2A multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CIP2A mRNA CTD PMID:19167446 NCBI chr11:54,373,794...54,404,704
Ensembl chr11:54,377,374...54,404,612
JBrowse link
G Cisd1 CDGSH iron sulfur domain 1 increases expression ISO Coumestrol results in increased expression of CISD1 mRNA CTD PMID:19167446 NCBI chr20:18,493,538...18,506,923
Ensembl chr20:18,493,538...18,506,912
JBrowse link
G Cit citron rho-interacting serine/threonine kinase multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CIT mRNA CTD PMID:19167446 NCBI chr12:46,334,669...46,494,152
Ensembl chr12:46,334,665...46,494,174
JBrowse link
G Cited2 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CITED2 mRNA CTD PMID:19167446 NCBI chr 1:12,823,363...12,825,806
Ensembl chr 1:12,823,363...12,825,786
JBrowse link
G Ckap2 cytoskeleton associated protein 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of CKAP2 mRNA CTD PMID:19167446 NCBI chr16:74,752,655...74,779,184
Ensembl chr16:74,752,655...74,779,184
JBrowse link
G Ckap2l cytoskeleton associated protein 2-like multiple interactions
increases expression
ISO [Coumestrol co-treated with resveratrol] results in increased expression of CKAP2L mRNA
Coumestrol results in increased expression of CKAP2L mRNA
CTD PMID:19167446 NCBI chr 3:121,796,221...121,822,352
Ensembl chr 3:121,796,238...121,822,436
JBrowse link
G Ckap4 cytoskeleton-associated protein 4 decreases expression ISO Coumestrol results in decreased expression of CKAP4 mRNA CTD PMID:19167446 NCBI chr 7:24,935,243...24,947,595
Ensembl chr 7:24,939,498...24,947,595
JBrowse link
G Ckap5 cytoskeleton associated protein 5 increases expression
multiple interactions
ISO Coumestrol results in increased expression of CKAP5 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKAP5 mRNA
CTD PMID:19167446 NCBI chr 3:80,424,320...80,526,583
Ensembl chr 3:80,468,154...80,526,593
JBrowse link
G Cklf chemokine-like factor increases expression
multiple interactions
ISO Coumestrol results in increased expression of CKLF mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKLF mRNA
CTD PMID:19167446 NCBI chr19:903,609...914,880
Ensembl chr19:906,411...914,880
JBrowse link
G Cks1b CDC28 protein kinase regulatory subunit 1B multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKS1B mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CKS1B mRNA
Coumestrol results in increased expression of CKS1B mRNA
CTD PMID:19167446 NCBI chr 2:188,740,564...188,745,144
Ensembl chr 2:188,740,573...188,745,144
JBrowse link
G Cks2 CDC28 protein kinase regulatory subunit 2 increases expression
multiple interactions
ISO Coumestrol results in increased expression of CKS2 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKS2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CKS2 mRNA
CTD PMID:19167446 NCBI chr17:13,587,664...13,593,423
Ensembl chr17:13,587,665...13,593,423
JBrowse link
G Clcc1 chloride channel CLIC-like 1 multiple interactions ISO [Coumestrol co-treated with ESR1 protein] results in increased expression of CLCC1 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CLCC1 mRNA] CTD PMID:18310284 NCBI chr 2:211,450,426...211,479,885
Ensembl chr 2:211,450,484...211,479,884
JBrowse link
G Cldn1 claudin 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLDN1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of CLDN1 mRNA CTD PMID:19167446 NCBI chr11:77,815,216...77,830,373
Ensembl chr11:77,815,181...77,830,416
JBrowse link
G Cldn4 claudin 4 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLDN4 mRNA CTD PMID:19167446 NCBI chr12:24,761,210...24,763,008
Ensembl chr12:24,761,210...24,763,005
JBrowse link
G Clip1 CAP-GLY domain containing linker protein 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLIP1 mRNA CTD PMID:19167446 NCBI chr12:38,345,203...38,452,650
Ensembl chr12:38,345,456...38,452,652
JBrowse link
G Cln6 CLN6, transmembrane ER protein multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CLN6 mRNA CTD PMID:19167446 NCBI chr 8:67,733,215...67,748,170
Ensembl chr 8:67,733,215...67,748,172
JBrowse link
G Cln8 CLN8, transmembrane ER and ERGIC protein decreases expression ISO Coumestrol results in decreased expression of CLN8 mRNA CTD PMID:19167446 NCBI chr16:79,828,321...79,838,212
Ensembl chr16:79,828,324...79,838,212
JBrowse link
G Cltrn collectrin, amino acid transport regulator decreases expression ISO Coumestrol results in decreased expression of CLTRN mRNA CTD PMID:19167446 NCBI chr  X:32,118,082...32,153,687
Ensembl chr  X:32,118,054...32,153,794
JBrowse link
G Clu clusterin multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLU mRNA CTD PMID:19167446 NCBI chr15:42,626,612...42,665,858
Ensembl chr15:42,640,146...42,665,857
JBrowse link
G Cmc2 C-x(9)-C motif containing 2 increases expression
multiple interactions
ISO Coumestrol results in increased expression of CMC2 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CMC2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CMC2 mRNA
CTD PMID:19167446 NCBI chr19:49,433,332...49,457,641
Ensembl chr19:49,433,590...49,448,072
JBrowse link
G Cmss1 cms1 ribosomal small subunit homolog increases expression
multiple interactions
ISO Coumestrol results in increased expression of CMSS1 mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of CMSS1 mRNA
CTD PMID:19167446 NCBI chr11:45,031,627...45,330,481
Ensembl chr11:45,304,068...45,330,481
JBrowse link
G Cmtm8 CKLF-like MARVEL transmembrane domain containing 8 decreases expression ISO Coumestrol results in decreased expression of CMTM8 mRNA CTD PMID:19167446 NCBI chr 8:122,848,249...122,913,597
Ensembl chr 8:122,848,501...122,904,913
JBrowse link
G Cobl cordon-bleu WH2 repeat protein decreases expression ISO Coumestrol results in decreased expression of COBL mRNA CTD PMID:19167446 NCBI chr14:92,341,949...92,497,169
Ensembl chr14:92,342,957...92,577,936
JBrowse link
G Coch cochlin increases expression ISO Coumestrol results in increased expression of COCH mRNA CTD PMID:19167446 NCBI chr 6:72,359,702...72,373,710
Ensembl chr 6:72,359,791...72,373,695
JBrowse link
G Cog4 component of oligomeric golgi complex 4 increases expression ISO Coumestrol results in increased expression of COG4 mRNA CTD PMID:19167446 NCBI chr19:43,358,057...43,391,828
Ensembl chr19:43,358,057...43,391,828
JBrowse link
G Cog5 component of oligomeric golgi complex 5 decreases expression ISO Coumestrol results in decreased expression of COG5 mRNA CTD PMID:19167446 NCBI chr 6:50,953,868...51,230,860
Ensembl chr 6:50,954,631...51,230,701
JBrowse link
G Cog6 component of oligomeric golgi complex 6 decreases expression ISO Coumestrol results in decreased expression of COG6 mRNA CTD PMID:19167446 NCBI chr 2:142,197,566...142,235,054
Ensembl chr 2:142,196,754...142,235,066
JBrowse link
G Commd4 COMM domain containing 4 increases expression ISO Coumestrol results in increased expression of COMMD4 mRNA CTD PMID:19167446 NCBI chr 8:61,833,340...61,836,872
Ensembl chr 8:61,833,326...61,836,945
JBrowse link
G Comt catechol-O-methyltransferase decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of COMT mRNA
[Coumestrol co-treated with resveratrol] results in decreased expression of COMT mRNA
CTD PMID:19167446 NCBI chr11:86,715,981...86,735,630
Ensembl chr11:86,715,981...86,735,622
JBrowse link
G Cops2 COP9 signalosome subunit 2 decreases expression ISO Coumestrol results in decreased expression of COPS2 mRNA CTD PMID:19167446 NCBI chr 3:118,109,394...118,137,125
Ensembl chr 3:118,109,406...118,137,191
JBrowse link
G Coq2 coenzyme Q2, polyprenyltransferase multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of COQ2 mRNA CTD PMID:19167446 NCBI chr14:10,581,102...10,601,093
Ensembl chr14:10,581,136...10,600,566
JBrowse link
G Coq7 coenzyme Q7, hydroxylase increases expression ISO Coumestrol results in increased expression of COQ7 mRNA CTD PMID:19167446 NCBI chr 1:188,176,060...188,190,874
Ensembl chr 1:188,174,874...188,190,860
JBrowse link
G Coro1b coronin 1B decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of CORO1B mRNA
[Coumestrol co-treated with resveratrol] results in decreased expression of CORO1B mRNA
CTD PMID:19167446 NCBI chr 1:219,397,827...219,403,253
Ensembl chr 1:219,397,850...219,403,260
JBrowse link
G Coro1c coronin 1C increases expression ISO Coumestrol results in increased expression of CORO1C mRNA CTD PMID:19167446 NCBI chr12:48,481,741...48,554,054
Ensembl chr12:48,481,750...48,554,052
JBrowse link
G Coro2a coronin 2A decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of CORO2A mRNA
[Coumestrol co-treated with resveratrol] results in decreased expression of CORO2A mRNA
CTD PMID:19167446 NCBI chr 5:62,154,526...62,210,797
Ensembl chr 5:62,156,839...62,187,930
JBrowse link
G Cpe carboxypeptidase E decreases expression ISO Coumestrol results in decreased expression of CPE mRNA CTD PMID:19167446 NCBI chr16:26,906,716...27,014,811
Ensembl chr16:26,906,716...27,014,813
JBrowse link
G Cpeb2 cytoplasmic polyadenylation element binding protein 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of CPEB2 mRNA CTD PMID:19167446 NCBI chr14:72,327,929...72,382,519
Ensembl chr14:72,331,705...72,380,330
JBrowse link
G Cpsf3 cleavage and polyadenylation specific factor 3 increases expression ISO Coumestrol results in increased expression of CPSF3 mRNA CTD PMID:19167446 NCBI chr 6:43,363,792...43,391,712
Ensembl chr 6:43,363,792...43,391,712
JBrowse link
G Cracd capping protein inhibiting regulator of actin dynamics multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CRACD mRNA
Coumestrol results in decreased expression of CRACD mRNA
CTD PMID:19167446 NCBI chr14:33,649,989...33,783,794
Ensembl chr14:33,649,637...33,677,031
JBrowse link
G Creb3l4 cAMP responsive element binding protein 3-like 4 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of CREB3L4 mRNA CTD PMID:19167446 NCBI chr 2:189,596,657...189,602,243
Ensembl chr 2:189,595,415...189,602,143
JBrowse link
G Crip2 cysteine-rich protein 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of CRIP2 mRNA CTD PMID:19167446 NCBI chr 6:137,953,545...137,958,491
Ensembl chr 6:137,953,545...137,958,490
JBrowse link
G Cry1 cryptochrome circadian regulator 1 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of CRY1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CRY1 mRNA
CTD PMID:19167446 NCBI chr 7:24,534,593...24,634,098
Ensembl chr 7:24,534,615...24,634,097
JBrowse link
G Cse1l chromosome segregation 1 like multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CSE1L mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CSE1L mRNA
Coumestrol results in increased expression of CSE1L mRNA
CTD PMID:19167446 NCBI chr 3:163,664,074...163,702,074
Ensembl chr 3:163,664,136...163,702,060
JBrowse link
G Csnk1a1 casein kinase 1, alpha 1 decreases expression ISO Coumestrol results in decreased expression of CSNK1A1 mRNA CTD PMID:19167446 NCBI chr18:56,887,722...56,910,610
Ensembl chr18:56,887,354...56,918,345
JBrowse link
G Csnk1g1 casein kinase 1, gamma 1 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of CSNK1G1 mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of CSNK1G1 mRNA
CTD PMID:19167446 NCBI chr 8:71,533,372...71,688,483
Ensembl chr 8:71,547,468...71,679,666
JBrowse link
G Csnk1g3 casein kinase 1, gamma 3 decreases expression ISO Coumestrol results in decreased expression of CSNK1G3 mRNA CTD PMID:19167446 NCBI chr18:48,831,209...48,913,341
Ensembl chr18:48,853,418...48,911,122
JBrowse link
G Csnk2a2 casein kinase 2 alpha 2 decreases expression ISO Coumestrol results in decreased expression of CSNK2A2 mRNA CTD PMID:19167446 NCBI chr19:9,972,537...10,012,043
Ensembl chr19:9,972,537...10,012,043
JBrowse link
G Cspg5 chondroitin sulfate proteoglycan 5 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CSPG5 mRNA CTD PMID:19167446 NCBI chr 8:118,333,695...118,348,040
Ensembl chr 8:118,333,706...118,347,582
JBrowse link
G Csrnp1 cysteine and serine rich nuclear protein 1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AXUD1 mRNA
Coumestrol results in decreased expression of AXUD1 mRNA
CTD PMID:19167446 NCBI chr 8:128,659,883...128,673,339
Ensembl chr 8:128,659,868...128,672,284
JBrowse link
G Csrnp2 cysteine and serine rich nuclear protein 2 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of CSRNP2 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CSRNP2 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of CSRNP2 mRNA
CTD PMID:19167446 NCBI chr 7:142,116,335...142,132,173
Ensembl chr 7:142,116,335...142,132,173
JBrowse link
G Csta cystatin A decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of CSTA mRNA
[Coumestrol co-treated with resveratrol] results in decreased expression of CSTA mRNA
CTD PMID:19167446 NCBI chr11:67,555,792...67,566,980
Ensembl chr11:67,555,658...67,566,972
JBrowse link
G Cstf1 cleavage stimulation factor subunit 1 increases expression ISO Coumestrol results in increased expression of CSTF1 mRNA CTD PMID:19167446 NCBI chr 3:170,380,413...170,392,162
Ensembl chr 3:170,380,719...170,392,160
JBrowse link
G Cstf2 cleavage stimulation factor subunit 2 increases expression ISO Coumestrol results in increased expression of CSTF2 mRNA CTD PMID:19167446 NCBI chr  X:104,882,726...104,909,746
Ensembl chr  X:104,882,704...104,909,739
JBrowse link
G Ctbp1 C-terminal binding protein 1 decreases expression ISO Coumestrol results in decreased expression of CTBP1 mRNA CTD PMID:19167446 NCBI chr14:82,762,109...82,789,350
Ensembl chr14:82,762,190...82,789,319
JBrowse link
G Ctdspl2 CTD small phosphatase like 2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CTDSPL2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CTDSPL2 mRNA
Coumestrol results in increased expression of CTDSPL2 mRNA
CTD PMID:19167446 NCBI chr 3:113,906,803...113,957,289
Ensembl chr 3:113,918,629...113,960,101
JBrowse link
G Ctnnal1 catenin alpha-like 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CTNNAL1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of CTNNAL1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CTNNAL1 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CTNNAL1 mRNA]
Coumestrol results in increased expression of CTNNAL1 mRNA
CTD PMID:18310284, PMID:19167446 NCBI chr 5:73,561,249...73,621,070
Ensembl chr 5:73,561,450...73,621,070
JBrowse link
G Ctnnd1 catenin delta 1 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of CTNND1 mRNA
[Coumestrol co-treated with resveratrol] results in decreased expression of CTNND1 mRNA
CTD PMID:19167446 NCBI chr 3:72,001,904...72,053,047
Ensembl chr 3:72,002,152...72,053,049
JBrowse link
G Ctnnd2 catenin delta 2 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of CTNND2 mRNA
[Coumestrol co-treated with resveratrol] results in decreased expression of CTNND2 mRNA
CTD PMID:19167446 NCBI chr 2:83,227,247...84,094,315
Ensembl chr 2:83,393,282...84,094,315
JBrowse link
G Ctps1 CTP synthase 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with resveratrol] results in increased expression of CTPS mRNA
Coumestrol results in increased expression of CTPS mRNA
CTD PMID:19167446 NCBI chr 5:139,475,934...139,505,065
Ensembl chr 5:139,475,934...139,505,065
JBrowse link
G Ctr9 CTR9 homolog, Paf1/RNA polymerase II complex component multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CTR9 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CTR9 mRNA CTD PMID:19167446 NCBI chr 1:175,839,140...175,869,167
Ensembl chr 1:175,839,108...175,869,165
JBrowse link
G Ctsb cathepsin B decreases expression ISO Coumestrol results in decreased expression of CTSB mRNA CTD PMID:19167446 NCBI chr15:46,316,741...46,337,613
Ensembl chr15:46,316,741...46,337,612
JBrowse link
G Ctsc cathepsin C increases expression ISO Coumestrol results in increased expression of CTSC mRNA CTD PMID:19167446 NCBI chr 1:151,918,514...151,949,979
Ensembl chr 1:151,918,571...151,949,983
JBrowse link
G Ctsh cathepsin H multiple interactions
decreases expression
ISO [Coumestrol co-treated with resveratrol] results in decreased expression of CTSH mRNA
Coumestrol results in decreased expression of CTSH mRNA
CTD PMID:19167446 NCBI chr 8:97,439,155...97,458,293
Ensembl chr 8:97,439,161...97,458,287
JBrowse link
G Cttn cortactin multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CTTN mRNA CTD PMID:19167446 NCBI chr 1:217,602,698...217,638,196
NCBI chr 1:215,255,385...215,290,882
Ensembl chr 1:217,602,698...217,638,152
Ensembl chr 1:217,602,698...217,638,152
JBrowse link
G Cttnbp2nl CTTNBP2 N-terminal like multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CTTNBP2NL mRNA; [Coumestrol co-treated with Resveratrol] results in decreased expression of CTTNBP2NL mRNA CTD PMID:19167446 NCBI chr 2:207,495,056...207,541,808
Ensembl chr 2:207,495,055...207,541,645
JBrowse link
G Cxcl12 C-X-C motif chemokine ligand 12 multiple interactions
increases expression
ISO [Coumestrol co-treated with ESR1 protein] results in increased expression of CXCL12 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CXCL12 mRNA; ESR1 protein inhibits the reaction [Coumestrol results in increased expression of CXCL12 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CXCL12 mRNA] CTD PMID:18310284, PMID:19167446, PMID:23384675, PMID:28396216 NCBI chr 4:149,261,044...149,273,891
Ensembl chr 4:149,261,044...149,273,891
JBrowse link
G Cxxc5 CXXC finger protein 5 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CXXC5 mRNA CTD PMID:19167446 NCBI chr18:28,626,386...28,656,916
Ensembl chr18:28,653,592...28,656,937
JBrowse link
G Cyb5b cytochrome b5 type B increases expression ISO Coumestrol results in increased expression of CYB5B mRNA CTD PMID:19167446 NCBI chr19:39,357,814...39,391,680
Ensembl chr19:39,357,791...39,393,189
JBrowse link
G Cyb5r1 cytochrome b5 reductase 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CYB5R1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of CYB5R1 mRNA CTD PMID:19167446 NCBI chr13:51,229,697...51,236,447
Ensembl chr13:51,229,890...51,236,463
JBrowse link
G Cyfip2 cytoplasmic FMR1 interacting protein 2 decreases expression ISO Coumestrol results in decreased expression of CYFIP2 mRNA CTD PMID:19167446 NCBI chr10:31,278,746...31,419,235
Ensembl chr10:31,278,746...31,419,235
JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 increases expression
multiple interactions
ISO Coumestrol results in increased expression of CYP1B1 mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of CYP1B1 mRNA
CTD PMID:19167446 NCBI chr 6:2,308,179...2,316,739
Ensembl chr 6:2,307,808...2,316,722
JBrowse link
G Cyp2r1 cytochrome P450, family 2, subfamily r, polypeptide 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CYP2R1 mRNA CTD PMID:19167446 NCBI chr 1:184,060,521...184,106,604
Ensembl chr 1:184,093,920...184,106,200
JBrowse link
G Cyp51 cytochrome P450, family 51 increases expression ISO Coumestrol results in increased expression of CYP51A1 mRNA CTD PMID:19167446 NCBI chr 4:27,175,564...27,194,018
Ensembl chr 4:27,175,243...27,194,018
JBrowse link
G Cyren cell cycle regulator of NHEJ increases expression ISO Coumestrol results in increased expression of CYREN mRNA CTD PMID:19167446 NCBI chr 4:62,391,770...62,397,162
Ensembl chr 4:62,391,770...62,396,035
JBrowse link
G Cyrib CYFIP related Rac1 interactor B decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of CYRIB mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CYRIB mRNA
CTD PMID:19167446 NCBI chr 7:104,514,566...104,641,875
Ensembl chr 7:104,516,391...104,556,419
JBrowse link
G Cyth2 cytohesin 2 decreases expression ISO Coumestrol results in decreased expression of CYTH2 mRNA CTD PMID:19167446 NCBI chr 1:101,796,349...101,803,407
Ensembl chr 1:101,796,349...101,803,200
JBrowse link
G Daam1 dishevelled associated activator of morphogenesis 1 decreases expression ISO Coumestrol results in decreased expression of DAAM1 mRNA CTD PMID:19167446 NCBI chr 6:94,606,675...94,739,026
Ensembl chr 6:94,636,222...94,739,026
JBrowse link
G Dancr differentiation antagonizing non-protein coding RNA multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DANCR mRNA CTD PMID:19167446 NCBI chr14:36,664,036...36,665,016 JBrowse link
G Dars2 aspartyl-tRNA synthetase 2 (mitochondrial) increases expression
multiple interactions
ISO Coumestrol results in increased expression of DARS2 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DARS2 mRNA
CTD PMID:19167446 NCBI chr13:78,857,638...78,885,464
Ensembl chr13:78,857,638...78,885,464
JBrowse link
G Dbf4 DBF4 zinc finger multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DBF4 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DBF4 mRNA
Coumestrol results in increased expression of DBF4 mRNA
CTD PMID:19167446 NCBI chr 4:22,898,527...22,914,091
Ensembl chr 4:22,898,527...22,914,177
JBrowse link
G Dbn1 drebrin 1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DBN1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of DBN1 mRNA
Coumestrol results in decreased expression of DBN1 mRNA
CTD PMID:19167446 NCBI chr17:9,679,511...9,693,878
Ensembl chr17:9,679,628...9,693,820
JBrowse link
G Dcaf15 DDB1 and CUL4 associated factor 15 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DCAF15 mRNA CTD PMID:19167446 NCBI chr19:25,212,469...25,219,803
Ensembl chr19:25,212,661...25,220,010
JBrowse link
G Dcaf4 DDB1 and CUL4 associated factor 4 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DCAF4 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of DCAF4 mRNA CTD PMID:19167446 NCBI chr 6:107,001,763...107,027,466
Ensembl chr 6:107,001,763...107,027,456
JBrowse link
G Dcaf5 DDB1 and CUL4 associated factor 5 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of DCAF5 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DCAF5 mRNA
CTD PMID:19167446 NCBI chr 6:103,516,586...103,605,288
Ensembl chr 6:103,516,586...103,605,256
JBrowse link
G Dck deoxycytidine kinase increases expression
multiple interactions
ISO Coumestrol results in increased expression of DCK mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of DCK mRNA
CTD PMID:19167446 NCBI chr14:20,935,442...20,952,939
Ensembl chr14:20,935,369...20,953,095
JBrowse link
G Dclk1 doublecortin-like kinase 1 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of DCLK1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DCLK1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of DCLK1 mRNA
CTD PMID:19167446 NCBI chr 2:144,646,255...144,939,389
Ensembl chr 2:144,646,308...144,936,927
JBrowse link
G Dclre1a DNA cross-link repair 1A increases expression
multiple interactions
ISO Coumestrol results in increased expression of DCLRE1A mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DCLRE1A mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DCLRE1A mRNA
CTD PMID:19167446 NCBI chr 1:277,335,792...277,355,701
Ensembl chr 1:277,335,790...277,355,075
JBrowse link
G Dclre1b DNA cross-link repair 1B multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DCLRE1B mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DCLRE1B mRNA
Coumestrol results in increased expression of DCLRE1B mRNA
CTD PMID:19167446 NCBI chr 2:206,285,085...206,293,599
Ensembl chr 2:206,285,089...206,293,599
JBrowse link
G Dcps decapping enzyme, scavenger increases expression ISO Coumestrol results in increased expression of DCPS mRNA CTD PMID:19167446 NCBI chr 8:36,321,992...36,374,665
Ensembl chr 8:36,321,993...36,374,673
JBrowse link
G Dctpp1 dCTP pyrophosphatase 1 increases expression ISO Coumestrol results in increased expression of DCTPP1 mRNA CTD PMID:19167446 NCBI chr 1:198,703,459...198,706,852
Ensembl chr 1:198,703,461...198,706,852
JBrowse link
G Ddah2 dimethylarginine dimethylaminohydrolase 2 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of DDAH2 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DDAH2 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of DDAH2 mRNA
CTD PMID:19167446 NCBI chr20:5,049,260...5,052,573
Ensembl chr20:5,049,496...5,052,585
JBrowse link
G Ddb2 damage specific DNA binding protein 2 increases expression
multiple interactions
ISO Coumestrol results in increased expression of DDB2 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DDB2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DDB2 mRNA
CTD PMID:19167446 NCBI chr 3:80,030,437...80,052,984
Ensembl chr 3:80,030,437...80,052,953
JBrowse link
G Ddias DNA damage-induced apoptosis suppressor multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DDIAS mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DDIAS mRNA
Coumestrol results in increased expression of DDIAS mRNA
CTD PMID:19167446 NCBI chr 1:157,675,754...157,700,064
Ensembl chr 1:157,675,765...157,700,064
JBrowse link
G Ddit4 DNA-damage-inducible transcript 4 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of DDIT4 mRNA
[Coumestrol co-treated with resveratrol] results in decreased expression of DDIT4 mRNA
CTD PMID:19167446 NCBI chr20:29,509,283...29,511,382
Ensembl chr20:29,509,289...29,511,382
JBrowse link
G Ddx11 DEAD/H-box helicase 11 increases expression ISO Coumestrol results in increased expression of DDX11 mRNA CTD PMID:19167446 NCBI chr 9:114,113,642...114,133,908
Ensembl chr 9:114,111,580...114,132,492
JBrowse link
G Ddx39a DExD-box helicase 39A increases expression ISO Coumestrol results in increased expression of DDX39A mRNA CTD PMID:19167446 NCBI chr19:24,846,530...24,854,886
Ensembl chr19:24,846,938...24,854,953
JBrowse link
G Ddx39b DExD-box helicase 39B multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DDX39B mRNA CTD PMID:19167446 NCBI chr20:4,806,103...4,818,600
Ensembl chr20:4,806,108...4,818,568
JBrowse link
G Ddx56 DEAD-box helicase 56 increases expression ISO Coumestrol results in increased expression of DDX56 mRNA CTD PMID:19167446 NCBI chr14:86,378,937...86,387,637
Ensembl chr14:86,376,808...86,387,608
JBrowse link
G Dek DEK proto-oncogene increases expression
multiple interactions
ISO Coumestrol results in increased expression of DEK mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of DEK mRNA
CTD PMID:19167446 NCBI chr17:17,965,872...17,987,836
Ensembl chr17:17,965,881...17,987,834
JBrowse link
G Dennd11 DENN domain containing 11 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of DENND11 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DENND11 mRNA
CTD PMID:19167446 NCBI chr 4:68,569,308...68,597,626
Ensembl chr 4:68,569,691...68,597,586
JBrowse link
G Dennd1a DENN domain containing 1A increases expression ISO Coumestrol results in increased expression of DENND1A mRNA CTD PMID:19167446 NCBI chr 3:22,061,120...22,501,502
Ensembl chr 3:22,058,400...22,500,765
JBrowse link
G Dennd1b DENN domain containing 1B decreases expression ISO Coumestrol results in decreased expression of DENND1B mRNA CTD PMID:19167446 NCBI chr13:56,015,813...56,242,041
Ensembl chr13:56,015,901...56,236,677
JBrowse link
G Dennd1c DENN domain containing 1C decreases expression ISO Coumestrol results in decreased expression of DENND1C mRNA CTD PMID:19167446 NCBI chr 9:9,976,015...9,982,349
Ensembl chr 9:9,970,209...9,982,295
JBrowse link
G Denr density regulated reinitiation and release factor increases expression ISO Coumestrol results in increased expression of DENR mRNA CTD PMID:19167446 NCBI chr12:38,095,717...38,117,758
Ensembl chr12:38,096,034...38,116,919
JBrowse link
G Depdc1 DEP domain containing 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DEPDC1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of DEPDC1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DEPDC1 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of DEPDC1 mRNA]
Coumestrol results in increased expression of DEPDC1 mRNA
CTD PMID:18310284, PMID:19167446 NCBI chr 2:264,704,738...264,738,265
Ensembl chr 2:264,704,769...264,738,257
JBrowse link
G Depdc1b DEP domain containing 1B multiple interactions ISO [Coumestrol co-treated with ESR1 protein] results in increased expression of DEPDC1B mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of DEPDC1B mRNA] CTD PMID:18310284 NCBI chr 2:39,980,796...40,069,982
Ensembl chr 2:40,000,313...40,069,975
JBrowse link
G Deptor DEP domain containing MTOR-interacting protein multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DEPTOR mRNA; [Coumestrol co-treated with Resveratrol] results in increased expression of DEPTOR mRNA
Coumestrol results in increased expression of DEPTOR mRNA
CTD PMID:19167446 NCBI chr 7:94,795,161...95,000,750
Ensembl chr 7:94,795,214...94,995,809
JBrowse link
G Dera deoxyribose-phosphate aldolase multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DERA mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DERA mRNA
Coumestrol results in increased expression of DERA mRNA
CTD PMID:19167446 NCBI chr 4:171,748,254...171,826,414
Ensembl chr 4:171,748,273...171,826,409
JBrowse link
G Desi2 desumoylating isopeptidase 2 increases expression ISO Coumestrol results in increased expression of DESI2 mRNA CTD PMID:19167446 NCBI chr13:96,111,800...96,156,693
Ensembl chr13:96,111,800...96,154,685
JBrowse link
G Dhcr7 7-dehydrocholesterol reductase multiple interactions
increases expression
ISO [Coumestrol co-treated with resveratrol] results in increased expression of DHCR7 mRNA
Coumestrol results in increased expression of DHCR7 mRNA
CTD PMID:19167446 NCBI chr 1:217,018,916...217,034,890
Ensembl chr 1:217,018,916...217,034,904
JBrowse link
G Dhfr dihydrofolate reductase multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DHFR mRNA; [Coumestrol co-treated with Resveratrol] results in increased expression of DHFR mRNA
Coumestrol results in increased expression of DHFR mRNA
CTD PMID:19167446 NCBI chr 2:21,931,887...21,958,927
Ensembl chr 2:21,931,493...21,962,453
JBrowse link
G Dhrs2 dehydrogenase/reductase 2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DHRS2 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of DHRS2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DHRS2 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of DHRS2 mRNA]
Coumestrol results in increased expression of DHRS2 mRNA
CTD PMID:18310284, PMID:19167446 NCBI chr15:33,876,701...33,891,559
Ensembl chr15:33,885,106...33,891,539
JBrowse link
G Dhrs7 dehydrogenase/reductase 7 decreases expression ISO Coumestrol results in decreased expression of DHRS7 mRNA CTD PMID:19167446 NCBI chr 6:95,522,577...95,541,393
Ensembl chr 6:95,522,577...95,541,393
JBrowse link
G Dhtkd1 dehydrogenase E1 and transketolase domain containing 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DHTKD1 mRNA
Coumestrol results in increased expression of DHTKD1 mRNA
CTD PMID:19167446 NCBI chr17:76,306,585...76,358,058
Ensembl chr17:76,306,585...76,358,058
JBrowse link
G Diaph3 diaphanous-related formin 3 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DIAPH3 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DIAPH3 mRNA CTD PMID:19167446 NCBI chr15:69,928,507...70,400,077
Ensembl chr15:70,039,424...70,399,924
JBrowse link
G Dicer1 dicer 1 ribonuclease III decreases expression ISO Coumestrol results in decreased expression of DICER1 mRNA CTD PMID:19167446 NCBI chr 6:128,388,084...128,453,234
Ensembl chr 6:128,388,053...128,434,183
JBrowse link
G Dip2c disco-interacting protein 2 homolog C multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DIP2C mRNA CTD PMID:19167446 NCBI chr17:63,426,688...63,810,183
Ensembl chr17:63,635,086...63,808,464
JBrowse link
G Dixdc1 DIX domain containing 1 decreases expression ISO Coumestrol results in decreased expression of DIXDC1 mRNA CTD PMID:19167446 NCBI chr 8:55,091,232...55,164,636
Ensembl chr 8:55,091,235...55,162,421
JBrowse link
G Dkc1 dyskerin pseudouridine synthase 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DKC1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DKC1 mRNA
Coumestrol results in increased expression of DKC1 mRNA
CTD PMID:19167446 NCBI chr  X:155,844,914...155,862,363
Ensembl chr  X:155,844,857...155,862,475
JBrowse link
G Dlat dihydrolipoamide S-acetyltransferase increases expression ISO Coumestrol results in increased expression of DLAT mRNA CTD PMID:19167446 NCBI chr 8:55,062,549...55,087,832
Ensembl chr 8:55,062,551...55,087,832
JBrowse link
G Dlgap5 DLG associated protein 5 increases expression
multiple interactions
ISO Coumestrol results in increased expression of DLGAP5 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DLGAP5 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DLGAP5 mRNA
CTD PMID:19167446 NCBI chr15:24,167,484...24,199,417
Ensembl chr15:24,167,486...24,199,341
JBrowse link
G Dlx2 distal-less homeobox 2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DLX2 mRNA CTD PMID:19167446 NCBI chr 3:58,180,088...58,181,971
Ensembl chr 3:58,180,088...58,181,971
JBrowse link
G Dmac2l distal membrane arm assembly complex 2 like decreases expression ISO Coumestrol results in decreased expression of DMAC2L mRNA CTD PMID:19167446 NCBI chr 6:92,057,782...92,076,022
Ensembl chr 6:92,057,807...92,076,021
JBrowse link
G Dmxl1 Dmx-like 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DMXL1 mRNA CTD PMID:19167446 NCBI chr18:44,468,762...44,644,769
Ensembl chr18:44,468,784...44,642,050
JBrowse link
G Dnaja2 DnaJ heat shock protein family (Hsp40) member A2 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of DNAJA2 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DNAJA2 mRNA
CTD PMID:19167446 NCBI chr19:22,569,999...22,588,143
Ensembl chr19:22,569,999...22,588,137
JBrowse link
G Dnajb9 DnaJ heat shock protein family (Hsp40) member B9 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of DNAJB9 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DNAJB9 mRNA
CTD PMID:19167446 NCBI chr 6:64,165,913...64,170,122
Ensembl chr 6:64,165,913...64,170,151
JBrowse link
G Dnajc1 DnaJ heat shock protein family (Hsp40) member C1 decreases expression ISO Coumestrol results in decreased expression of DNAJC1 mRNA CTD PMID:19167446 NCBI chr17:84,986,994...85,141,464
Ensembl chr17:84,986,991...85,141,210
JBrowse link
G Dnajc16 DnaJ heat shock protein family (Hsp40) member C16 decreases expression ISO Coumestrol results in decreased expression of DNAJC16 mRNA CTD PMID:19167446 NCBI chr 5:160,325,088...160,352,874
Ensembl chr 5:160,325,107...160,352,927
JBrowse link
G Dnajc9 DnaJ heat shock protein family (Hsp40) member C9 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DNAJC9 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DNAJC9 mRNA
Coumestrol results in increased expression of DNAJC9 mRNA
CTD PMID:19167446 NCBI chr15:4,356,512...4,360,788
Ensembl chr15:4,356,261...4,360,564
JBrowse link
G Dnase2 deoxyribonuclease 2, lysosomal multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DNASE2 mRNA CTD PMID:19167446 NCBI chr19:26,022,855...26,025,523
Ensembl chr19:26,022,849...26,025,532
JBrowse link
G Dnm1l dynamin 1-like multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DNM1L mRNA CTD PMID:19167446 NCBI chr11:88,830,968...88,882,271
Ensembl chr11:88,830,957...88,880,198
JBrowse link
G Dnmt1 DNA methyltransferase 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DNMT1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DNMT1 mRNA
Coumestrol results in increased expression of DNMT1 mRNA
CTD PMID:19167446 NCBI chr 8:21,922,515...21,968,495
Ensembl chr 8:21,922,515...21,968,495
JBrowse link
G Dock8 dedicator of cytokinesis 8 decreases expression ISO Coumestrol results in decreased expression of DOCK8 mRNA CTD PMID:19167446 NCBI chr 1:242,934,685...243,153,472
Ensembl chr 1:242,959,488...243,153,465
JBrowse link
G Donson DNA replication fork stabilization factor DONSON increases expression
multiple interactions
ISO Coumestrol results in increased expression of DONSON mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DONSON mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DONSON mRNA
CTD PMID:19167446 NCBI chr11:31,834,608...31,847,751
Ensembl chr11:31,837,839...31,847,490
JBrowse link
G Dop1b DOP1 leucine zipper like protein B decreases expression ISO Coumestrol results in decreased expression of DOP1B mRNA CTD PMID:19167446 NCBI chr11:33,929,142...34,027,447
Ensembl chr11:33,925,498...34,027,435
JBrowse link
G Dpagt1 dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 increases expression ISO Coumestrol results in increased expression of DPAGT1 mRNA CTD PMID:19167446 NCBI chr 8:48,657,779...48,664,531
Ensembl chr 8:48,657,795...48,664,860
JBrowse link
G Dpm2 dolichyl-phosphate mannosyltransferase subunit 2, regulatory increases expression ISO Coumestrol results in increased expression of DPM2 mRNA CTD PMID:19167446 NCBI chr 3:11,587,941...11,590,528
Ensembl chr 3:11,587,941...11,590,528
JBrowse link
G Dpy19l1 dpy-19 like C-mannosyltransferase 1 increases expression ISO Coumestrol results in increased expression of DPY19L1 mRNA CTD PMID:19167446 NCBI chr 8:25,582,938...25,669,394
Ensembl chr 8:25,582,938...25,669,394
JBrowse link
G Dsc2 desmocollin 2 decreases expression ISO Coumestrol results in decreased expression of DSC2 mRNA CTD PMID:19167446 NCBI chr18:11,826,705...11,858,801
Ensembl chr18:11,826,706...11,858,754
JBrowse link
G Dscc1 DNA replication and sister chromatid cohesion 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DSCC1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DSCC1 mRNA
Coumestrol results in increased expression of DSCC1 mRNA
CTD PMID:19167446 NCBI chr 7:94,759,076...94,774,787
Ensembl chr 7:94,758,800...94,774,569
JBrowse link
G Dsn1 DSN1 component of MIS12 kinetochore complex multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DSN1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DSN1 mRNA
Coumestrol results in increased expression of DSN1 mRNA
CTD PMID:19167446 NCBI chr 3:153,101,020...153,115,326
Ensembl chr 3:153,101,036...153,114,520
JBrowse link
G Dtna dystrobrevin, alpha decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of DTNA mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DTNA mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of DTNA mRNA
CTD PMID:19167446 NCBI chr18:14,544,725...14,671,514
Ensembl chr18:14,471,213...14,657,332
JBrowse link
G Dusp1 dual specificity phosphatase 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DUSP1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of DUSP1 mRNA CTD PMID:19167446 NCBI chr10:16,970,642...16,973,425
Ensembl chr10:16,970,626...16,973,418
JBrowse link
G Dusp10 dual specificity phosphatase 10 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of DUSP10 mRNA
[Coumestrol co-treated with resveratrol] results in decreased expression of DUSP10 mRNA
CTD PMID:19167446 NCBI chr13:104,284,660...104,321,455
Ensembl chr13:104,284,660...104,321,455
JBrowse link
G Dusp22 dual specificity phosphatase 22 decreases expression ISO Coumestrol results in decreased expression of DUSP22 mRNA CTD PMID:19167446 NCBI chr17:34,986,589...35,037,297
Ensembl chr17:34,986,591...35,037,076
JBrowse link
G Dut deoxyuridine triphosphatase increases expression
multiple interactions
ISO Coumestrol results in increased expression of DUT mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DUT mRNA; [Coumestrol co-treated with Resveratrol] results in increased expression of DUT mRNA
CTD PMID:19167446 NCBI chr 3:117,514,399...117,525,450
Ensembl chr 3:117,514,444...117,525,446
JBrowse link
G Dync1li1 dynein cytoplasmic 1 light intermediate chain 1 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of DYNC1LI1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DYNC1LI1 mRNA
CTD PMID:19167446 NCBI chr 8:122,743,274...122,776,801
Ensembl chr 8:122,743,189...122,776,806
JBrowse link
G Dync2i2 dynein 2 intermediate chain 2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DYNC2I2 mRNA CTD PMID:19167446 NCBI chr 3:8,599,251...8,615,329
Ensembl chr 3:8,599,148...8,615,532
JBrowse link
G Dynlt3 dynein light chain Tctex-type 3 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of DYNLT3 mRNA CTD PMID:19167446 NCBI chr  X:14,633,342...14,642,356
Ensembl chr  X:14,633,342...14,642,424
JBrowse link
G E2f1 E2F transcription factor 1 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of E2F1 mRNA CTD PMID:19167446 NCBI chr 3:150,062,895...150,073,721
Ensembl chr 3:150,047,826...150,073,721
JBrowse link
G E2f2 E2F transcription factor 2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of E2F2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of E2F2 mRNA
Coumestrol results in increased expression of E2F2 mRNA
CTD PMID:19167446 NCBI chr 5:154,516,611...154,540,228
Ensembl chr 5:154,522,119...154,540,265
JBrowse link
G E2f5 E2F transcription factor 5 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of E2F5 mRNA
Coumestrol results in decreased expression of E2F5 mRNA
CTD PMID:19167446 NCBI chr 2:88,350,764...88,366,913
Ensembl chr 2:88,351,361...88,366,115
JBrowse link
G E2f7 E2F transcription factor 7 increases expression
multiple interactions
ISO Coumestrol results in increased expression of E2F7 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of E2F7 mRNA; [Coumestrol co-treated with Resveratrol] results in increased expression of E2F7 mRNA
CTD PMID:19167446 NCBI chr 7:53,275,659...53,318,261
Ensembl chr 7:53,275,676...53,316,481
JBrowse link
G E2f8 E2F transcription factor 8 increases expression
multiple interactions
ISO Coumestrol results in increased expression of E2F8 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of E2F8 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of E2F8 mRNA
CTD PMID:19167446 NCBI chr 1:104,185,436...104,203,683
Ensembl chr 1:104,187,100...104,202,591
JBrowse link
G Ebp EBP, cholestenol delta-isomerase increases expression
multiple interactions
ISO Coumestrol results in increased expression of EBP mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EBP mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of EBP mRNA
CTD PMID:19167446 NCBI chr  X:15,049,394...15,055,782
Ensembl chr  X:15,049,462...15,055,781
JBrowse link
G Ect2 epithelial cell transforming 2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ECT2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ECT2 mRNA
Coumestrol results in increased expression of ECT2 mRNA
CTD PMID:19167446 NCBI chr 2:112,769,385...112,831,476
Ensembl chr 2:112,769,385...112,831,476
JBrowse link
G Edem3 ER degradation enhancing alpha-mannosidase like protein 3 decreases expression ISO Coumestrol results in decreased expression of EDEM3 mRNA CTD PMID:19167446 NCBI chr13:69,135,095...69,197,708
Ensembl chr13:69,135,128...69,199,511
JBrowse link
G Edil3 EGF like repeats and discoidin domains 3 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EDIL3 mRNA CTD PMID:19167446 NCBI chr 2:17,616,116...18,128,514
Ensembl chr 2:17,616,401...18,128,512
JBrowse link
G Edn1 endothelin 1 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of EDN1 mRNA
[Coumestrol co-treated with resveratrol] results in decreased expression of EDN1 mRNA
CTD PMID:19167446 NCBI chr17:22,136,814...22,143,745
Ensembl chr17:22,137,324...22,143,324
JBrowse link
G Eed embryonic ectoderm development increases expression
multiple interactions
ISO Coumestrol results in increased expression of EED mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EED mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of EED mRNA
CTD PMID:19167446 NCBI chr 1:154,189,252...154,216,340
Ensembl chr 1:154,189,260...154,216,340
JBrowse link
G Eef1a1 eukaryotic translation elongation factor 1 alpha 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EEF1A1 mRNA CTD PMID:19167446 NCBI chr 8:85,838,594...85,841,816
Ensembl chr 8:85,838,869...85,840,818
JBrowse link
G Efemp1 EGF containing fibulin extracellular matrix protein 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFEMP1 mRNA CTD PMID:19167446 NCBI chr14:113,202,382...113,294,993
Ensembl chr14:113,202,419...113,295,014
JBrowse link
G Efhd1 EF-hand domain family, member D1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFHD1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of EFHD1 mRNA
Coumestrol results in decreased expression of EFHD1 mRNA
CTD PMID:19167446 NCBI chr 9:94,362,249...94,408,884
Ensembl chr 9:94,362,299...94,408,885
JBrowse link
G Efna1 ephrin A1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFNA1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of EFNA1 mRNA
Coumestrol results in decreased expression of EFNA1 mRNA
CTD PMID:19167446 NCBI chr 2:188,588,808...188,596,156
Ensembl chr 2:188,588,796...188,596,222
JBrowse link
G Efnb2 ephrin B2 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFNB2 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of EFNB2 mRNA
Coumestrol results in decreased expression of EFNB2 mRNA
CTD PMID:19167446 NCBI chr16:86,631,151...86,672,050
Ensembl chr16:86,631,064...86,675,049
JBrowse link
G Efnb3 ephrin B3 decreases expression ISO Coumestrol results in decreased expression of EFNB3 mRNA CTD PMID:19167446 NCBI chr10:56,161,431...56,168,819
Ensembl chr10:56,161,432...56,167,426
JBrowse link
G Eftud2 elongation factor Tu GTP binding domain containing 2 increases expression ISO Coumestrol results in increased expression of EFTUD2 mRNA CTD PMID:19167446 NCBI chr10:90,932,071...90,983,971
Ensembl chr10:90,932,075...90,983,928
JBrowse link
G Egr1 early growth response 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EGR1 mRNA CTD PMID:19167446 NCBI chr18:27,657,903...27,660,101
Ensembl chr18:27,657,628...27,661,429
JBrowse link
G Egr3 early growth response 3 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EGR3 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of EGR3 mRNA CTD PMID:19167446 NCBI chr15:51,756,683...51,762,080
Ensembl chr15:51,756,736...51,760,722
JBrowse link
G Ehmt1 euchromatic histone lysine methyltransferase 1 decreases expression ISO Coumestrol results in decreased expression of EHMT1 mRNA CTD PMID:19167446 NCBI chr 3:1,966,974...2,123,858
Ensembl chr 3:1,960,957...2,123,820
JBrowse link
G Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 decreases expression ISO Coumestrol results in decreased expression of EIF2AK3 mRNA CTD PMID:19167446 NCBI chr 4:98,648,513...98,709,695
Ensembl chr 4:98,648,545...98,709,694
JBrowse link
G Eif2s1 eukaryotic translation initiation factor 2 subunit alpha increases expression ISO Coumestrol results in increased expression of EIF2S1 mRNA CTD PMID:19167446 NCBI chr 6:102,048,372...102,073,041
Ensembl chr 6:102,048,372...102,073,041
JBrowse link
G Eif4ebp2 eukaryotic translation initiation factor 4E binding protein 2 increases expression ISO Coumestrol results in increased expression of EIF4EBP2 mRNA CTD PMID:19167446 NCBI chr20:31,055,292...31,072,469
Ensembl chr20:31,055,789...31,072,469
JBrowse link
G Eif4g3 eukaryotic translation initiation factor 4 gamma, 3 decreases expression ISO Coumestrol results in decreased expression of EIF4G3 mRNA CTD PMID:19167446 NCBI chr 5:156,343,663...156,564,037
Ensembl chr 5:156,396,695...156,564,037
JBrowse link
G Elapor1 endosome-lysosome associated apoptosis and autophagy regulator 1 multiple interactions ISO [Coumestrol co-treated with Resveratrol] results in decreased expression of ELAPOR1 mRNA CTD PMID:19167446 NCBI chr 2:211,243,398...211,323,283
Ensembl chr 2:211,246,068...211,322,719
JBrowse link
G Elf5 E74 like ETS transcription factor 5 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ELF5 mRNA CTD PMID:19167446 NCBI chr 3:93,333,514...93,374,454
Ensembl chr 3:93,351,619...93,371,656
JBrowse link
G Elk1 ETS transcription factor ELK1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELK1 mRNA CTD PMID:19167446 NCBI chr  X:1,287,875...1,304,822
Ensembl chr  X:1,297,099...1,304,822
JBrowse link
G Elk3 ETS transcription factor ELK3 decreases expression ISO Coumestrol results in decreased expression of ELK3 mRNA CTD PMID:19167446 NCBI chr 7:34,086,213...34,149,601
Ensembl chr 7:34,086,220...34,121,694
JBrowse link
G Elmo2 engulfment and cell motility 2 decreases expression ISO Coumestrol results in decreased expression of ELMO2 mRNA CTD PMID:19167446 NCBI chr 3:161,812,474...161,850,006
Ensembl chr 3:161,812,474...162,003,588
JBrowse link
G Elovl2 ELOVL fatty acid elongase 2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELOVL2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ELOVL2 mRNA
Coumestrol results in increased expression of ELOVL2 mRNA
CTD PMID:19167446 NCBI chr17:21,382,461...21,422,413
Ensembl chr17:21,382,455...21,422,407
JBrowse link
G Elovl5 ELOVL fatty acid elongase 5 increases expression
multiple interactions
ISO Coumestrol results in increased expression of ELOVL5 mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of ELOVL5 mRNA
CTD PMID:19167446 NCBI chr 8:85,220,941...85,287,449
Ensembl chr 8:85,259,982...85,285,983
JBrowse link
G Elovl6 ELOVL fatty acid elongase 6 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELOVL6 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ELOVL6 mRNA
Coumestrol results in increased expression of ELOVL6 mRNA
CTD PMID:19167446 NCBI chr 2:234,187,490...234,296,124
Ensembl chr 2:234,189,105...234,296,145
Ensembl chr 2:234,189,105...234,296,145
JBrowse link
G Elovl7 ELOVL fatty acid elongase 7 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELOVL7 mRNA; [Coumestrol co-treated with Resveratrol] results in increased expression of ELOVL7 mRNA
Coumestrol results in increased expression of ELOVL7 mRNA
CTD PMID:19167446 NCBI chr 2:40,373,211...40,386,643
Ensembl chr 2:40,373,211...40,386,669
JBrowse link
G Elp5 elongator acetyltransferase complex subunit 5 multiple interactions
increases expression
ISO [Coumestrol co-treated with resveratrol] results in increased expression of ELP5 mRNA
Coumestrol results in increased expression of ELP5 mRNA
CTD PMID:19167446 NCBI chr10:56,578,980...56,590,706
Ensembl chr10:56,578,985...56,591,364
JBrowse link
G Elp6 elongator acetyltransferase complex subunit 6 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELP6 mRNA
Coumestrol results in increased expression of ELP6 mRNA
CTD PMID:19167446 NCBI chr 8:118,525,770...118,541,074
Ensembl chr 8:118,525,682...118,541,073
JBrowse link
G Emc9 ER membrane protein complex subunit 9 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EMC9 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of EMC9 mRNA
Coumestrol results in increased expression of EMC9 mRNA
CTD PMID:19167446 NCBI chr15:34,258,940...34,263,156
Ensembl chr15:34,256,374...34,263,224
JBrowse link
G Emd emerin increases expression ISO Coumestrol results in increased expression of EMD mRNA CTD PMID:19167446 NCBI chr  X:156,452,847...156,455,858
Ensembl chr  X:156,452,818...156,456,035
JBrowse link
G Eme1 essential meiotic structure-specific endonuclease 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EME1 mRNA CTD PMID:19167446 NCBI chr10:82,366,820...82,375,510
Ensembl chr10:82,367,084...82,374,171
JBrowse link
G Enc1 ectodermal-neural cortex 1 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of ENC1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ENC1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of ENC1 mRNA
CTD PMID:19167446 NCBI chr 2:28,049,217...28,061,023
Ensembl chr 2:28,049,217...28,061,029
JBrowse link
G Endod1 endonuclease domain containing 1 increases expression
multiple interactions
ISO Coumestrol results in increased expression of ENDOD1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ENDOD1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ENDOD1 mRNA
CTD PMID:19167446 NCBI chr 8:12,898,430...12,928,156 JBrowse link
G Entpd2 ectonucleoside triphosphate diphosphohydrolase 2 decreases expression ISO Coumestrol results in decreased expression of ENTPD2 mRNA CTD PMID:19167446 NCBI chr 3:2,617,795...2,623,818
Ensembl chr 3:2,617,805...2,623,445
JBrowse link
G Entpd4 ectonucleoside triphosphate diphosphohydrolase 4 decreases expression ISO Coumestrol results in decreased expression of ENTPD4 mRNA CTD PMID:19167446 NCBI chr15:51,222,954...51,250,787
Ensembl chr15:51,222,954...51,250,787
JBrowse link
G Epb41l2 erythrocyte membrane protein band 4.1-like 2 decreases expression ISO Coumestrol results in decreased expression of EPB41L2 mRNA CTD PMID:19167446 NCBI chr 1:20,881,820...21,067,713
Ensembl chr 1:20,893,995...20,962,526
JBrowse link
G Epb41l5 erythrocyte membrane protein band 4.1 like 5 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EPB41L5 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of EPB41L5 mRNA
Coumestrol results in decreased expression of EPB41L5 mRNA
CTD PMID:19167446 NCBI chr13:35,622,472...35,673,449
Ensembl chr13:35,580,098...35,668,968
JBrowse link
G Epha4 Eph receptor A4 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EPHA4 mRNA CTD PMID:19167446 NCBI chr 9:83,111,222...83,253,486
Ensembl chr 9:83,111,222...83,253,458
JBrowse link
G Eps15l1 epidermal growth factor receptor pathway substrate 15-like 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EPS15L1 mRNA
Coumestrol results in increased expression of EPS15L1 mRNA
CTD PMID:19167446 NCBI chr16:19,127,635...19,202,991
Ensembl chr16:19,127,724...19,203,003
JBrowse link
G Erbb2 erb-b2 receptor tyrosine kinase 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of ERBB2 mRNA CTD PMID:19167446 NCBI chr10:86,367,596...86,391,728
Ensembl chr10:86,367,596...86,391,728
JBrowse link
G Erbb3 erb-b2 receptor tyrosine kinase 3 decreases expression ISO Coumestrol results in decreased expression of ERBB3 mRNA CTD PMID:19167446 NCBI chr 7:2,989,202...3,010,610
Ensembl chr 7:2,989,340...3,010,350
JBrowse link
G Erbb4 erb-b2 receptor tyrosine kinase 4 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of ERBB4 mRNA CTD PMID:19167446 NCBI chr 9:75,021,790...76,178,936
Ensembl chr 9:75,021,790...75,528,644
JBrowse link
G Ercc6l ERCC excision repair 6 like, spindle assembly checkpoint helicase increases expression
multiple interactions
ISO Coumestrol results in increased expression of ERCC6L mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ERCC6L mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ERCC6L mRNA
CTD PMID:19167446 NCBI chr  X:72,018,373...72,034,140
Ensembl chr  X:72,018,373...72,034,099
JBrowse link
G Eri2 ERI1 exoribonuclease family member 2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ERI2 mRNA CTD PMID:19167446 NCBI chr 1:189,540,145...189,549,891
Ensembl chr 1:189,540,145...189,549,891
JBrowse link
G Errfi1 ERBB receptor feedback inhibitor 1 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of ERRFI1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ERRFI1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of ERRFI1 mRNA
CTD PMID:19167446 NCBI chr 5:167,951,564...167,966,011
Ensembl chr 5:167,952,728...167,966,009
JBrowse link
G Esco2 establishment of sister chromatid cohesion N-acetyltransferase 2 increases expression ISO Coumestrol results in increased expression of ESCO2 mRNA CTD PMID:19167446 NCBI chr15:42,500,929...42,519,019
Ensembl chr15:42,500,929...42,518,855
JBrowse link
G Espl1 extra spindle pole bodies like 1, separase multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ESPL1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ESPL1 mRNA
Coumestrol results in increased expression of ESPL1 mRNA
CTD PMID:19167446 NCBI chr 7:143,896,890...143,923,868
Ensembl chr 7:143,897,014...143,923,868
JBrowse link
G Esr1 estrogen receptor 1 multiple interactions
affects response to substance
increases activity
affects binding
decreases expression
ISO
EXP
2,2-bis(4-glycidyloxyphenyl)propane analog inhibits the reaction [Coumestrol binds to ESR1 protein]; 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Coumestrol binds to ESR1 protein]; 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane inhibits the reaction [Coumestrol binds to ESR1 protein modified form]; 4,4'-hexafluorisopropylidene diphenol inhibits the reaction [Coumestrol binds to ESR1 protein modified form]; [Coumestrol binds to ESR1 protein] which results in increased activity of ALPL protein; [Coumestrol co-treated with ESR1 protein] results in increased expression of ADRA2A mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of ANLN mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of ANP32E mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of ASPM mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of AURKA mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of BIN3 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of CCNA2 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of CDCA3 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of CDKN2C mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of CDKN3 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of CENPF mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of CLCC1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of CTNNAL1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of CXCL12 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of DEPDC1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of DEPDC1B mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of DHRS2 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of EXOSC9 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of FABP5 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of FCMR mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of FHL1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of GAL mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of GPSM2 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of GREB1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of GTSE1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of HMGB2 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of HMMR mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of IGFBP4 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of IL17RB mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of IL20 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of IRS1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of KCNK5 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of KIF14 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of KIF15 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of KIF18A mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of KIF20A mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of MKI67 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of MYB mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of MYC mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of NCAPG mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of NEK2 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of NPY1R mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of NUSAP1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of PDLIM3 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of PDZK1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of PIF1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of PKIB mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of PLK1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of RACGAP1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of RASGRP1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of RERG mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of SLC26A2 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of SPC25 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of ST8SIA6 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of STC2 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of TFF1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of TMPRSS3 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of TOP2A mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of TRAF4 mRNA; Benzo(a)pyrene inhibits the reaction [Coumestrol binds to ESR1 protein modified form]; bisphenol F diglycidyl ether analog inhibits the reaction [Coumestrol binds to ESR1 protein]; bisphenol F diglycidyl ether inhibits the reaction [Coumestrol binds to ESR1 protein]; CCND1 protein promotes the reaction [Coumestrol results in increased activity of ESR1 protein]; Coumestrol binds to and results in increased activity of ESR1 protein; Coumestrol inhibits the reaction [16 alpha-iodoestradiol binds to ESR1 protein]; Coumestrol inhibits the reaction [Estradiol binds to ESR1 protein]; Coumestrol promotes the reaction [NCOA2 protein binds to ESR1 protein]; Diethylstilbestrol inhibits the reaction [Coumestrol binds to ESR1 protein]; ESR1 protein inhibits the reaction [Coumestrol results in increased expression of CCN5 mRNA]; ESR1 protein inhibits the reaction [Coumestrol results in increased expression of CXCL12 mRNA]; ESR1 protein inhibits the reaction [Coumestrol results in increased expression of PGR mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of ADRA2A mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of ANLN mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of ANP32E mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of ASPM mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of AURKA mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of BIN3 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CCNA2 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CDCA3 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CENPF mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CLCC1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CTNNAL1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CXCL12 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of DEPDC1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of DEPDC1B mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of DHRS2 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of EXOSC9 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of FABP5 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of FCMR mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of FHL1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of GAL mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of GPSM2 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of GREB1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of GTSE1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of HMGB2 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of HMMR mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of IGFBP4 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of IL17RB mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of IL20 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of IRS1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of KCNK5 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of KIF18A mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of MKI67 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of MYB mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of MYC mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of NCAPG mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of NEK2 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of NPY1R mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of NUSAP1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of PDLIM3 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of PDZK1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of PIF1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of PKIB mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of PLK1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of RACGAP1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of RASGRP1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of RERG mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of SLC26A2 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of SPC25 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of ST8SIA6 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of STC2 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of TFF1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of TMPRSS3 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of TRAF4 mRNA]; ESR2 protein promotes the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CDKN2C mRNA]; ESR2 protein promotes the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CDKN3 mRNA]; ESR2 protein promotes the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of KIF14 mRNA]; ESR2 protein promotes the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of KIF15 mRNA]; ESR2 protein promotes the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of KIF20A mRNA]; ESR2 protein promotes the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of TOP2A mRNA]; Estradiol inhibits the reaction [Coumestrol binds to ESR1 protein]; Fulvestrant inhibits the reaction [[Coumestrol binds to ESR1 protein] which results in increased activity of ALPL protein]; Fulvestrant inhibits the reaction [Coumestrol results in increased activity of ESR1 protein]; Tamoxifen inhibits the reaction [Coumestrol results in increased activity of ESR1 protein]; Tamoxifen promotes the reaction [Coumestrol results in increased activity of ESR1 protein mutant form]; tetrabromobisphenol A inhibits the reaction [Coumestrol binds to ESR1 protein modified form]; tetrachlorodian inhibits the reaction [Coumestrol binds to ESR1 protein modified form]
ESR1 protein affects the susceptibility to Coumestrol
Coumestrol results in decreased expression of ESR1 protein
Coumestrol binds to ESR1 protein; Coumestrol binds to ESR1 protein modified form
CTD PMID:9048584, PMID:9751507, PMID:10397250, PMID:11162928, PMID:11518614, PMID:11867264, PMID:12650720, PMID:12765243, PMID:15084758, PMID:15876408, PMID:16118406, PMID:16328721, PMID:16566672, PMID:17174995, PMID:17275032, PMID:18310284, PMID:19400946, PMID:19913605, PMID:22562034, PMID:23384675, PMID:28396216, PMID:29152682, PMID:29162470, PMID:30143207, PMID:32619634 NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
JBrowse link
G Esr2 estrogen receptor 2 multiple interactions
increases expression
affects response to substance
affects binding
increases activity
ISO
EXP
Coumestrol binds to and results in increased activity of ESR2 protein; Coumestrol inhibits the reaction [Estradiol binds to ESR2 protein]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of ADRA2A mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of ANLN mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of ANP32E mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of ASPM mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of AURKA mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of BIN3 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CCNA2 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CDCA3 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CENPF mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CLCC1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CTNNAL1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CXCL12 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of DEPDC1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of DEPDC1B mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of DHRS2 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of EXOSC9 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of FABP5 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of FCMR mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of FHL1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of GAL mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of GPSM2 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of GREB1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of GTSE1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of HMGB2 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of HMMR mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of IGFBP4 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of IL17RB mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of IL20 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of IRS1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of KCNK5 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of KIF18A mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of MKI67 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of MYB mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of MYC mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of NCAPG mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of NEK2 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of NPY1R mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of NUSAP1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of PDLIM3 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of PDZK1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of PIF1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of PKIB mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of PLK1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of RACGAP1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of RASGRP1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of RERG mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of SLC26A2 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of SPC25 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of ST8SIA6 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of STC2 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of TFF1 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of TMPRSS3 mRNA]; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of TRAF4 mRNA]; ESR2 protein promotes the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CDKN2C mRNA]; ESR2 protein promotes the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of CDKN3 mRNA]; ESR2 protein promotes the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of KIF14 mRNA]; ESR2 protein promotes the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of KIF15 mRNA]; ESR2 protein promotes the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of KIF20A mRNA]; ESR2 protein promotes the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of TOP2A mRNA]
Coumestrol results in increased expression of ESR2 protein; Coumestrol results in increased expression of ESR2 protein alternative form
ESR2 protein affects the susceptibility to Coumestrol
ESR2 protein affects the reaction [Coumestrol results in increased expression of SOD2 protein]
Coumestrol binds to ESR2 protein
Coumestrol inhibits the reaction [16 alpha-iodoestradiol binds to ESR2 protein]; Coumestrol inhibits the reaction [Estradiol binds to ESR2 protein alternative form]
Coumestrol results in increased activity of ESR2 protein
CTD PMID:9048584, PMID:9492041, PMID:9751507, PMID:11518614, PMID:12224631, PMID:12765243, PMID:15084758, PMID:16118406, PMID:16566672, PMID:17275032, PMID:18310284, PMID:19913605, PMID:21708076, PMID:23526725, PMID:27634370 NCBI chr 6:99,163,953...99,214,711
Ensembl chr 6:99,164,357...99,214,251
JBrowse link
G Esyt2 extended synaptotagmin 2 decreases expression ISO Coumestrol results in decreased expression of ESYT2 mRNA CTD PMID:19167446 NCBI chr 6:144,156,021...144,248,374
Ensembl chr 6:144,156,175...144,245,545
JBrowse link
G Etnk1 ethanolamine kinase 1 decreases expression ISO Coumestrol results in decreased expression of ETNK1 mRNA CTD PMID:19167446 NCBI chr 4:177,402,904...177,447,047
Ensembl chr 4:177,402,904...177,447,028
JBrowse link
G Evi5 ecotropic viral integration site 5 decreases expression ISO Coumestrol results in decreased expression of EVI5 mRNA CTD PMID:19167446 NCBI chr14:2,892,738...3,038,237
Ensembl chr14:2,892,753...3,038,237
JBrowse link
G Exo1 exonuclease 1 increases expression
multiple interactions
ISO Coumestrol results in increased expression of EXO1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EXO1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of EXO1 mRNA
CTD PMID:19167446 NCBI chr13:93,936,989...93,962,749
Ensembl chr13:93,939,022...93,960,342
JBrowse link
G Exoc2 exocyst complex component 2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EXOC2 mRNA CTD PMID:19167446 NCBI chr17:34,665,810...34,842,266
Ensembl chr17:34,665,872...34,842,266
JBrowse link
G Exosc2 exosome component 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of EXOSC2 mRNA CTD PMID:19167446 NCBI chr 3:10,151,734...10,161,997
Ensembl chr 3:10,151,284...10,161,989
JBrowse link
G Exosc3 exosome component 3 increases expression ISO Coumestrol results in increased expression of EXOSC3 mRNA CTD PMID:19167446 NCBI chr 5:60,866,498...60,871,734
Ensembl chr 5:60,868,502...60,871,705
JBrowse link
G Exosc8 exosome component 8 increases expression ISO Coumestrol results in increased expression of EXOSC8 mRNA CTD PMID:19167446 NCBI chr 2:143,925,643...143,932,240
Ensembl chr 2:143,925,546...143,931,940
JBrowse link
G Exosc9 exosome component 9 multiple interactions ISO [Coumestrol co-treated with ESR1 protein] results in increased expression of EXOSC9 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of EXOSC9 mRNA] CTD PMID:18310284 NCBI chr 2:123,264,679...123,275,623
Ensembl chr 2:123,264,694...123,294,880
JBrowse link
G Ext1 exostosin glycosyltransferase 1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EXT1 mRNA
Coumestrol results in decreased expression of EXT1 mRNA
CTD PMID:19167446 NCBI chr 7:92,605,008...92,881,392
Ensembl chr 7:92,605,728...92,882,068
JBrowse link
G Ezh2 enhancer of zeste 2 polycomb repressive complex 2 subunit increases expression
multiple interactions
ISO Coumestrol results in increased expression of EZH2 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EZH2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of EZH2 mRNA
CTD PMID:19167446 NCBI chr 4:77,284,404...77,347,011
Ensembl chr 4:77,284,404...77,347,011
JBrowse link
G Ezr ezrin multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EZR mRNA CTD PMID:19167446 NCBI chr 1:47,287,872...47,331,412
Ensembl chr 1:47,287,874...47,331,412
JBrowse link
G F2r coagulation factor II (thrombin) receptor decreases expression ISO Coumestrol results in decreased expression of F2R mRNA CTD PMID:19167446 NCBI chr 2:26,118,760...26,135,340
Ensembl chr 2:26,118,760...26,135,340
JBrowse link
G F2rl1 F2R like trypsin receptor 1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of F2RL1 mRNA
Coumestrol results in decreased expression of F2RL1 mRNA
CTD PMID:19167446 NCBI chr 2:25,222,324...25,235,275
Ensembl chr 2:25,222,328...25,235,275
JBrowse link
G Fabp5 fatty acid binding protein 5 multiple interactions ISO [Coumestrol co-treated with ESR1 protein] results in increased expression of FABP5 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of FABP5 mRNA] CTD PMID:18310284 NCBI chr 2:93,981,662...93,985,322
Ensembl chr 2:93,981,656...93,985,378
JBrowse link
G Fads1 fatty acid desaturase 1 increases expression
multiple interactions
ISO Coumestrol results in increased expression of FADS1 mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of FADS1 mRNA
CTD PMID:19167446 NCBI chr 1:226,234,034...226,249,118
Ensembl chr 1:226,234,074...226,249,138
JBrowse link
G Fah fumarylacetoacetate hydrolase increases expression ISO Coumestrol results in increased expression of FAH mRNA CTD PMID:19167446 NCBI chr 1:146,713,663...146,736,339
Ensembl chr 1:146,713,676...146,736,261
JBrowse link
G Fam107b family with sequence similarity 107, member B multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM107B mRNA; [Coumestrol co-treated with Resveratrol] results in decreased expression of FAM107B mRNA
Coumestrol results in decreased expression of FAM107B mRNA
CTD PMID:19167446 NCBI chr17:78,489,667...78,689,933
Ensembl chr17:78,489,668...78,561,613
JBrowse link
G Fam110b family with sequence similarity 110, member B multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM110B mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of FAM110B mRNA
Coumestrol results in decreased expression of FAM110B mRNA
CTD PMID:19167446 NCBI chr 5:18,762,488...18,903,818
Ensembl chr 5:18,901,039...18,902,672
JBrowse link
G Fam110c family with sequence similarity 110, member C decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of FAM110C mRNA
[Coumestrol co-treated with resveratrol] results in decreased expression of FAM110C mRNA
CTD PMID:19167446 NCBI chr 6:49,968,473...49,974,730
Ensembl chr 6:49,968,473...49,974,728
JBrowse link
G Fam111a FAM111 trypsin like peptidase A multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FAM111A mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of FAM111A mRNA
Coumestrol results in increased expression of FAM111A mRNA
CTD PMID:19167446 NCBI chr 1:229,003,778...229,019,532
Ensembl chr 1:229,003,961...229,019,527
JBrowse link
G Fam126b family with sequence similarity 126, member B decreases expression ISO Coumestrol results in decreased expression of FAM126B mRNA CTD PMID:19167446 NCBI chr 9:65,406,136...65,478,399
Ensembl chr 9:65,406,138...65,442,257
JBrowse link
G Fam149b1 family with sequence similarity 149, member B1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM149B1 mRNA; [Coumestrol co-treated with Resveratrol] results in decreased expression of FAM149B1 mRNA
Coumestrol results in decreased expression of FAM149B1 mRNA
CTD PMID:19167446 NCBI chr15:4,361,860...4,399,746
Ensembl chr15:4,361,862...4,399,685
JBrowse link
G Fam161b FAM161 centrosomal protein B decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of FAM161B mRNA
[Coumestrol co-treated with resveratrol] results in decreased expression of FAM161B mRNA
CTD PMID:19167446 NCBI chr 6:108,060,019...108,076,303
Ensembl chr 6:108,061,063...108,076,186
JBrowse link
G Fam169a family with sequence similarity 169, member A decreases expression ISO Coumestrol results in decreased expression of FAM169A mRNA CTD PMID:19167446 NCBI chr 2:27,884,748...27,941,069
Ensembl chr 2:27,905,535...27,938,525
JBrowse link
G Fam171b family with sequence similarity 171, member B multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of FAM171B mRNA CTD PMID:19167446 NCBI chr 3:71,210,048...71,265,419
Ensembl chr 3:71,210,301...71,262,615
JBrowse link
G Fam174b family with sequence similarity 174, member B decreases expression ISO Coumestrol results in decreased expression of FAM174B mRNA CTD PMID:19167446 NCBI chr 1:135,081,596...135,180,266
Ensembl chr 1:135,083,974...135,162,685
JBrowse link
G Fam189a2 family with sequence similarity 189, member A2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM189A2 mRNA CTD PMID:19167446 NCBI chr 1:241,822,152...241,876,089
Ensembl chr 1:241,822,626...241,875,864
JBrowse link
G Fam210b family with sequence similarity 210, member B decreases expression ISO Coumestrol results in decreased expression of FAM210B mRNA CTD PMID:19167446 NCBI chr 3:170,354,109...170,364,265
Ensembl chr 3:170,354,141...170,362,513
JBrowse link
G Fam214a family with sequence similarity 214, member A decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of FAM214A mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM214A mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of FAM214A mRNA
CTD PMID:19167446 NCBI chr 8:81,863,619...81,941,548
Ensembl chr 8:81,863,619...81,941,536
JBrowse link
G Fam216a family with sequence similarity 216, member A increases expression ISO Coumestrol results in increased expression of FAM216A mRNA CTD PMID:19167446 NCBI chr12:39,679,688...39,688,831
Ensembl chr12:39,679,688...39,688,823
JBrowse link
G Fam222b family with sequence similarity 222, member B decreases expression ISO Coumestrol results in decreased expression of FAM222B mRNA CTD PMID:19167446 NCBI chr10:65,351,245...65,416,869
Ensembl chr10:65,351,245...65,416,869
JBrowse link
G Fam43a family with sequence similarity 43, member A multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM43A mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of FAM43A mRNA
Coumestrol results in decreased expression of FAM43A mRNA
CTD PMID:19167446 NCBI chr11:73,676,601...73,679,003
Ensembl chr11:73,676,601...73,678,984
JBrowse link
G Fanca FA complementation group A multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of FANCA mRNA CTD PMID:19167446 NCBI chr19:56,067,548...56,126,075
Ensembl chr19:56,067,548...56,126,063
JBrowse link
G Fancd2 FA complementation group D2 increases expression
multiple interactions
ISO Coumestrol results in increased expression of FANCD2 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCD2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of FANCD2 mRNA
CTD PMID:19167446 NCBI chr 4:145,489,869...145,551,479
Ensembl chr 4:145,489,869...145,551,479
JBrowse link
G Fancg FA complementation group G multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCG mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of FANCG mRNA
Coumestrol results in increased expression of FANCG mRNA
CTD PMID:19167446 NCBI chr 5:58,448,060...58,456,416
Ensembl chr 5:58,448,822...58,455,819
JBrowse link
G Fanci FA complementation group I multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCI mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of FANCI mRNA
Coumestrol results in increased expression of FANCI mRNA
CTD PMID:19167446 NCBI chr 1:141,116,565...141,172,997
Ensembl chr 1:141,120,166...141,172,483
JBrowse link
G Fancl FA complementation group L multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCL mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of FANCL mRNA CTD PMID:19167446 NCBI chr14:110,675,306...110,740,880
Ensembl chr14:110,676,090...110,740,317
JBrowse link
G Farsb phenylalanyl-tRNA synthetase subunit beta increases expression ISO Coumestrol results in increased expression of FARSB mRNA CTD PMID:19167446 NCBI chr 9:84,324,456...84,383,674
Ensembl chr 9:84,324,442...84,383,687
JBrowse link
G Fblim1 filamin binding LIM protein 1 decreases expression ISO Coumestrol results in decreased expression of FBLIM1 mRNA CTD PMID:19167446 NCBI chr 5:160,122,466...160,158,921
Ensembl chr 5:160,122,425...160,158,386
JBrowse link
G Fbxl5 F-box and leucine-rich repeat protein 5 decreases expression ISO Coumestrol results in decreased expression of FBXL5 mRNA CTD PMID:19167446 NCBI chr14:71,852,649...71,891,143
Ensembl chr14:71,852,682...71,891,143
JBrowse link
G Fbxo38 F-box protein 38 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FBXO38 mRNA CTD PMID:19167446 NCBI chr18:57,827,391...57,874,515
Ensembl chr18:57,827,392...57,866,741
JBrowse link
G Fbxo5 F-box protein 5 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FBXO5 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of FBXO5 mRNA
Coumestrol results in increased expression of FBXO5 mRNA
CTD PMID:19167446 NCBI chr 1:42,461,277...42,467,646
Ensembl chr 1:42,461,291...42,467,586
JBrowse link
G Fcf1 FCF1 rRNA-processing protein increases expression ISO Coumestrol results in increased expression of FCF1 mRNA CTD PMID:19167446 NCBI chr 6:108,796,182...108,808,051
Ensembl chr 6:108,796,182...108,808,048
JBrowse link
G Fcmr Fc fragment of IgM receptor multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FCMR mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of FCMR mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of FCMR mRNA] CTD PMID:18310284, PMID:19167446 NCBI chr13:47,602,701...47,617,065
Ensembl chr13:47,602,692...47,617,064
JBrowse link
G Fdft1 farnesyl diphosphate farnesyl transferase 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FDFT1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of FDFT1 mRNA
Coumestrol results in increased expression of FDFT1 mRNA
CTD PMID:19167446 NCBI chr15:46,339,248...46,367,302
Ensembl chr15:46,339,249...46,367,302
JBrowse link
G Fdps farnesyl diphosphate synthase multiple interactions
increases expression
ISO [Coumestrol co-treated with resveratrol] results in increased expression of FDPS mRNA
Coumestrol results in increased expression of FDPS mRNA
CTD PMID:19167446 NCBI chr 2:188,403,595...188,413,219
Ensembl chr 2:188,392,858...188,413,219
JBrowse link
G Fen1 flap structure-specific endonuclease 1 increases expression
multiple interactions
ISO Coumestrol results in increased expression of FEN1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FEN1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of FEN1 mRNA
CTD PMID:19167446 NCBI chr 1:226,251,516...226,256,160
Ensembl chr 1:226,251,518...226,255,886
JBrowse link
G Fermt2 fermitin family member 2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FERMT2 mRNA CTD PMID:19167446 NCBI chr15:19,807,806...19,876,557
Ensembl chr15:19,807,808...19,876,408
JBrowse link
G Fgfr1 Fibroblast growth factor receptor 1 decreases expression ISO Coumestrol results in decreased expression of FGFR1 mRNA CTD PMID:19167446 NCBI chr16:71,265,390...71,319,046
Ensembl chr16:71,266,248...71,319,449
JBrowse link
G Fh fumarate hydratase increases expression ISO Coumestrol results in increased expression of FH mRNA CTD PMID:19167446 NCBI chr13:93,651,486...93,677,371
Ensembl chr13:93,651,484...93,677,377
JBrowse link
G Fhl1 four and a half LIM domains 1 multiple interactions ISO [Coumestrol co-treated with ESR1 protein] results in increased expression of FHL1 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of FHL1 mRNA] CTD PMID:18310284 NCBI chr  X:159,112,516...159,172,528
Ensembl chr  X:159,112,880...159,172,524
JBrowse link
G Fhl2 four and a half LIM domains 2 multiple interactions
increases expression
ISO [Coumestrol co-treated with resveratrol] results in increased expression of FHL2 mRNA
Coumestrol results in increased expression of FHL2 mRNA
CTD PMID:19167446 NCBI chr 9:49,920,611...49,994,906
Ensembl chr 9:49,920,854...49,950,093
JBrowse link
G Fibp FGF1 intracellular binding protein multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FIBP mRNA CTD PMID:19167446 NCBI chr 1:220,840,078...220,844,412
Ensembl chr 1:220,840,118...220,844,405
JBrowse link
G Fignl1 fidgetin-like 1 increases expression
multiple interactions
ISO Coumestrol results in increased expression of FIGNL1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FIGNL1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of FIGNL1 mRNA
CTD PMID:19167446 NCBI chr14:91,895,902...91,904,474
Ensembl chr14:91,895,909...91,904,433
JBrowse link
G Filip1l filamin A interacting protein 1-like multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FILIP1L mRNA CTD PMID:19167446 NCBI chr11:45,039,488...45,275,141
Ensembl chr11:45,039,461...45,124,423
JBrowse link
G Fkbp11 FKBP prolyl isomerase 11 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FKBP11 mRNA; [Coumestrol co-treated with Resveratrol] results in increased expression of FKBP11 mRNA
Coumestrol results in increased expression of FKBP11 mRNA
CTD PMID:19167446 NCBI chr 7:140,398,253...140,402,664
Ensembl chr 7:140,398,199...140,437,467
JBrowse link
G Fkbp4 FKBP prolyl isomerase 4 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FKBP4 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of FKBP4 mRNA
Coumestrol results in increased expression of FKBP4 mRNA
CTD PMID:19167446 NCBI chr 4:161,748,993...161,757,447
Ensembl chr 4:161,748,993...161,757,447
JBrowse link
G Fkbp5 FKBP prolyl isomerase 5 multiple interactions
increases expression
ISO [Coumestrol co-treated with resveratrol] results in increased expression of FKBP5 mRNA
Coumestrol results in increased expression of FKBP5 mRNA
CTD PMID:19167446 NCBI chr20:7,976,704...8,097,290
Ensembl chr20:7,976,713...8,019,020
JBrowse link
G Fkbpl FKBP prolyl isomerase like increases expression ISO Coumestrol results in increased expression of FKBPL mRNA CTD PMID:19167446 NCBI chr20:4,411,890...4,413,360
Ensembl chr20:4,411,876...4,413,366
JBrowse link
G Flcn folliculin decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of FLCN mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FLCN mRNA
CTD PMID:19167446 NCBI chr10:46,153,185...46,172,331
Ensembl chr10:46,153,188...46,172,309
JBrowse link
G Fmnl2 formin-like 2 decreases expression ISO Coumestrol results in decreased expression of FMNL2 mRNA CTD PMID:19167446 NCBI chr 3:38,400,409...38,677,637
Ensembl chr 3:38,559,914...38,675,878
JBrowse link
G Fnbp1 formin binding protein 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FNBP1 mRNA CTD PMID:19167446 NCBI chr 3:9,865,657...9,936,333
Ensembl chr 3:9,861,237...9,936,405
JBrowse link
G Fnbp1l formin binding protein 1-like multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FNBP1L mRNA
Coumestrol results in decreased expression of FNBP1L mRNA
CTD PMID:19167446 NCBI chr 2:226,691,435...226,742,081
Ensembl chr 2:226,688,844...226,779,440
JBrowse link
G Fndc3b fibronectin type III domain containing 3B decreases expression ISO Coumestrol results in decreased expression of FNDC3B mRNA CTD PMID:19167446 NCBI chr 2:113,109,949...113,415,171
Ensembl chr 2:113,112,902...113,345,577
JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FOS mRNA CTD PMID:19167446 NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
JBrowse link
G Foxd1 forkhead box D1 decreases expression ISO Coumestrol results in decreased expression of FOXD1 mRNA CTD PMID:19167446 NCBI chr 2:28,460,068...28,462,488
Ensembl chr 2:28,460,068...28,462,488
JBrowse link
G Foxm1 forkhead box M1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FOXM1 mRNA; [Coumestrol co-treated with Resveratrol] results in increased expression of FOXM1 mRNA
Coumestrol results in increased expression of FOXM1 mRNA
CTD PMID:19167446 NCBI chr 4:161,685,236...161,697,633
Ensembl chr 4:161,685,258...161,696,305
JBrowse link
G Foxo3 forkhead box O3 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FOXO3 mRNA
Coumestrol results in decreased expression of FOXO3 mRNA
CTD PMID:19167446 NCBI chr20:46,428,078...46,519,156
Ensembl chr20:46,428,124...46,519,144
JBrowse link
G Foxp2 forkhead box P2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FOXP2 mRNA CTD PMID:19167446 NCBI chr 4:41,364,441...41,944,685
Ensembl chr 4:41,364,441...41,942,023
JBrowse link
G Foxred2 FAD-dependent oxidoreductase domain containing 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of FOXRED2 mRNA CTD PMID:19167446 NCBI chr 7:119,172,189...119,186,670
Ensembl chr 7:119,170,181...119,185,238
JBrowse link
G Frmd3 FERM domain containing 3 decreases expression ISO Coumestrol results in decreased expression of FRMD3 mRNA CTD PMID:19167446 NCBI chr 5:90,040,495...90,282,327
Ensembl chr 5:90,040,495...90,282,327
JBrowse link
G Frmd6 FERM domain containing 6 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FRMD6 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of FRMD6 mRNA
Coumestrol results in decreased expression of FRMD6 mRNA
CTD PMID:19167446 NCBI chr 6:93,281,382...93,358,888
Ensembl chr 6:93,281,408...93,358,840
JBrowse link
G Fscn1 fascin actin-bundling protein 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FSCN1 mRNA CTD PMID:19167446 NCBI chr12:13,655,459...13,668,595
Ensembl chr12:13,656,554...13,668,515
JBrowse link
G Ftsj1 FtsJ RNA 2'-O-methyltransferase 1 increases expression ISO Coumestrol results in increased expression of FTSJ1 mRNA CTD PMID:19167446 NCBI chr  X:14,993,685...15,006,010
Ensembl chr  X:14,994,016...15,002,074
JBrowse link
G Fuca1 alpha-L-fucosidase 1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with resveratrol] results in decreased expression of FUCA1 mRNA
Coumestrol results in decreased expression of FUCA1 mRNA
CTD PMID:19167446 NCBI chr 5:154,269,296...154,286,545
Ensembl chr 5:154,269,118...154,286,544
JBrowse link
G Fv1 Friend virus susceptibility 1 increases expression ISO Coumestrol results in increased expression of C19ORF48 mRNA CTD PMID:19167446 NCBI chr 1:100,220,789...100,226,725
Ensembl chr 1:100,224,401...100,226,725
JBrowse link
G Fyb2 FYN binding protein 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of FYB2 mRNA CTD PMID:19167446 NCBI chr 5:124,442,386...124,561,766 JBrowse link
G Fyco1 FYVE and coiled-coil domain autophagy adaptor 1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FYCO1 mRNA
Coumestrol results in decreased expression of FYCO1 mRNA
CTD PMID:19167446 NCBI chr 8:132,844,042...132,910,905
Ensembl chr 8:132,844,043...132,911,193
JBrowse link
G Fzd2 frizzled class receptor 2 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of FZD2 mRNA CTD PMID:19167446 NCBI chr10:90,550,147...90,552,057
Ensembl chr10:90,550,147...90,552,057
JBrowse link
G G2e3 G2/M-phase specific E3 ubiquitin protein ligase multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of G2E3 mRNA
Coumestrol results in increased expression of G2E3 mRNA
CTD PMID:19167446 NCBI chr 6:72,092,148...72,123,878
Ensembl chr 6:72,092,194...72,122,497
JBrowse link
G G3bp2 G3BP stress granule assembly factor 2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of G3BP2 mRNA CTD PMID:19167446 NCBI chr14:17,437,145...17,523,254
Ensembl chr14:17,492,081...17,520,792
JBrowse link
G Gabpb2 GA binding protein transcription factor subunit beta 2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GABPB2 mRNA
Coumestrol results in increased expression of GABPB2 mRNA
CTD PMID:19167446 NCBI chr 2:196,357,030...196,392,514
Ensembl chr 2:196,359,243...196,377,883
JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible, alpha decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of GADD45A mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GADD45A mRNA
CTD PMID:19167446 NCBI chr 4:97,782,512...97,784,814
Ensembl chr 4:97,782,512...97,784,842
JBrowse link
G Gadd45gip1 GADD45G interacting protein 1 increases expression ISO Coumestrol results in increased expression of GADD45GIP1 mRNA CTD PMID:19167446 NCBI chr19:25,946,979...25,949,528
Ensembl chr19:25,946,979...25,949,528
JBrowse link
G Gal galanin and GMAP prepropeptide multiple interactions ISO [Coumestrol co-treated with ESR1 protein] results in increased expression of GAL mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of GAL mRNA] CTD PMID:18310284 NCBI chr 1:218,653,059...218,657,922
Ensembl chr 1:218,652,917...218,657,925
JBrowse link
G Galns galactosamine (N-acetyl)-6-sulfatase multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNS mRNA CTD PMID:19167446 NCBI chr19:55,391,004...55,423,328
Ensembl chr19:55,389,462...55,423,150
JBrowse link
G Galnt1 polypeptide N-acetylgalactosaminyltransferase 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNT1 mRNA CTD PMID:19167446 NCBI chr18:16,141,062...16,187,271
Ensembl chr18:16,146,447...16,185,496
JBrowse link
G Galnt10 polypeptide N-acetylgalactosaminyltransferase 10 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNT10 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of GALNT10 mRNA
Coumestrol results in decreased expression of GALNT10 mRNA
CTD PMID:19167446 NCBI chr10:43,067,316...43,208,992
Ensembl chr10:43,067,299...43,210,427
JBrowse link
G Galnt7 polypeptide N-acetylgalactosaminyltransferase 7 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNT7 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of GALNT7 mRNA
Coumestrol results in decreased expression of GALNT7 mRNA
CTD PMID:19167446 NCBI chr16:35,935,059...36,062,734
Ensembl chr16:35,934,970...36,062,719
JBrowse link
G Ganab glucosidase II alpha subunit multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GANAB mRNA CTD PMID:19167446 NCBI chr 1:225,096,558...225,116,384
Ensembl chr 1:225,096,598...225,116,378
JBrowse link
G Gart phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase increases expression ISO Coumestrol results in increased expression of GART mRNA CTD PMID:19167446 NCBI chr11:31,780,477...31,805,728
Ensembl chr11:31,780,487...31,805,728
JBrowse link
G Gas2l3 growth arrest-specific 2 like 3 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GAS2L3 mRNA; [Coumestrol co-treated with Resveratrol] results in increased expression of GAS2L3 mRNA CTD PMID:19167446 NCBI chr 7:29,963,129...29,996,021
Ensembl chr 7:29,959,597...29,986,163
JBrowse link
G Gata2 GATA binding protein 2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GATA2 mRNA CTD PMID:19167446 NCBI chr 4:120,129,028...120,142,490
Ensembl chr 4:120,133,713...120,142,488
JBrowse link
G Gata3 GATA binding protein 3 decreases expression ISO Coumestrol results in decreased expression of GATA3 mRNA CTD PMID:19167446 NCBI chr17:72,419,752...72,452,043
Ensembl chr17:72,429,618...72,450,681
JBrowse link
G Gatad1 GATA zinc finger domain containing 1 decreases expression ISO Coumestrol results in decreased expression of GATAD1 mRNA CTD PMID:19167446 NCBI chr 4:27,647,005...27,658,533
Ensembl chr 4:27,647,335...27,657,167
JBrowse link
G Gbp2 guanylate binding protein 2 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GBP2 mRNA CTD PMID:19167446 NCBI chr 2:248,276,795...248,293,784
Ensembl chr 2:248,276,709...248,293,784
JBrowse link
G Gchfr GTP cyclohydrolase I feedback regulator multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GCHFR mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of GCHFR mRNA
Coumestrol results in increased expression of GCHFR mRNA
CTD PMID:19167446 NCBI chr 3:110,975,923...110,979,957
Ensembl chr 3:110,975,923...110,979,957
JBrowse link
G Gclm glutamate cysteine ligase, modifier subunit multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of GCLM mRNA CTD PMID:19167446 NCBI chr 2:225,827,504...225,847,876
Ensembl chr 2:225,827,504...225,847,874
JBrowse link
G Gdf15 growth differentiation factor 15 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GDF15 mRNA
Coumestrol results in decreased expression of GDF15 mRNA
CTD PMID:19167446 NCBI chr16:20,555,395...20,557,978
Ensembl chr16:20,555,395...20,557,978
JBrowse link
G Gdpd3 glycerophosphodiester phosphodiesterase domain containing 3 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GDPD3 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of GDPD3 mRNA
Coumestrol results in decreased expression of GDPD3 mRNA
CTD PMID:19167446 NCBI chr 1:198,199,032...198,209,178
Ensembl chr 1:198,199,622...198,209,150
JBrowse link
G Gem GTP binding protein overexpressed in skeletal muscle increases expression ISO Coumestrol results in increased expression of GEM mRNA CTD PMID:19167446 NCBI chr 5:25,339,479...25,353,661
Ensembl chr 5:25,349,928...25,353,661
JBrowse link
G Gemin2 gem (nuclear organelle) associated protein 2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GEMIN2 mRNA
Coumestrol results in increased expression of GEMIN2 mRNA
CTD PMID:19167446 NCBI chr 6:80,108,751...80,122,382
Ensembl chr 6:80,108,655...80,122,365
JBrowse link
G Gemin4 gem (nuclear organelle) associated protein 4 increases expression ISO Coumestrol results in increased expression of GEMIN4 mRNA CTD PMID:19167446 NCBI chr10:64,364,808...64,375,885
Ensembl chr10:64,368,809...64,375,816
JBrowse link
G Gemin6 gem (nuclear organelle) associated protein 6 increases expression ISO Coumestrol results in increased expression of GEMIN6 mRNA CTD PMID:19167446 NCBI chr 6:2,907,040...2,911,577
Ensembl chr 6:2,907,145...2,911,559
JBrowse link
G Gfra1 GDNF family receptor alpha 1 increases expression
multiple interactions
ISO Coumestrol results in increased expression of GFRA1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GFRA1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of GFRA1 mRNA
CTD PMID:19167446 NCBI chr 1:279,203,046...279,572,789 JBrowse link
G Gga2 golgi associated, gamma adaptin ear containing, ARF binding protein 2 increases expression ISO Coumestrol results in increased expression of GGA2 mRNA CTD PMID:19167446 NCBI chr 1:191,951,578...191,984,858
Ensembl chr 1:191,951,581...191,984,858
JBrowse link
G Ggct gamma-glutamyl cyclotransferase multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GGCT mRNA CTD PMID:19167446 NCBI chr 4:85,186,644...85,192,857
Ensembl chr 4:85,186,644...85,192,834
JBrowse link
G Ggh gamma-glutamyl hydrolase multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GGH mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of GGH mRNA
Coumestrol results in increased expression of GGH mRNA
CTD PMID:19167446 NCBI chr 5:34,040,258...34,063,369
Ensembl chr 5:34,040,258...34,063,361
JBrowse link
G Gins1 GINS complex subunit 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of GINS1 mRNA
Coumestrol results in increased expression of GINS1 mRNA
CTD PMID:19167446 NCBI chr 3:146,695,366...146,716,787
Ensembl chr 3:146,695,344...146,716,816
JBrowse link
G Gins2 GINS complex subunit 2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of GINS2 mRNA
Coumestrol results in increased expression of GINS2 mRNA
CTD PMID:19167446 NCBI chr19:54,151,048...54,163,701
Ensembl chr19:54,151,048...54,163,608
JBrowse link
G Gins3 GINS complex subunit 3 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS3 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of GINS3 mRNA
Coumestrol results in increased expression of GINS3 mRNA
CTD PMID:19167446 NCBI chr19:9,835,113...9,843,649
Ensembl chr19:9,835,057...9,843,673
JBrowse link
G Gins4 GINS complex subunit 4 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS4 mRNA CTD PMID:19167446 NCBI chr16:73,584,412...73,596,808
Ensembl chr16:73,584,521...73,596,793
JBrowse link
G Gla galactosidase, alpha multiple interactions
increases expression
ISO [Coumestrol co-treated with resveratrol] results in increased expression of GLA mRNA
Coumestrol results in increased expression of GLA mRNA
CTD PMID:19167446 NCBI chr  X:105,405,915...105,417,331
Ensembl chr  X:105,406,792...105,417,323
JBrowse link
G Gle1 GLE1 RNA export mediator increases expression
multiple interactions
ISO Coumestrol results in increased expression of GLE1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GLE1 mRNA
CTD PMID:19167446 NCBI chr 3:8,498,098...8,530,218
Ensembl chr 3:8,498,122...8,526,771
JBrowse link
G Glmn glomulin, FKBP associated protein increases expression ISO Coumestrol results in increased expression of GLMN mRNA CTD PMID:19167446 NCBI chr14:3,204,390...3,247,703
Ensembl chr14:3,204,390...3,247,695
JBrowse link
G Glmp glycosylated lysosomal membrane protein multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of GLMP mRNA CTD PMID:19167446 NCBI chr 2:187,697,528...187,701,118
Ensembl chr 2:187,697,523...187,701,118
JBrowse link
G Gls glutaminase decreases expression ISO Coumestrol results in decreased expression of GLS mRNA CTD PMID:19167446 NCBI chr 9:54,212,622...54,284,879
Ensembl chr 9:54,212,767...54,284,872
JBrowse link
G Gmnn geminin, DNA replication inhibitor multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GMNN mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of GMNN mRNA
Coumestrol results in increased expression of GMNN mRNA
CTD PMID:19167446 NCBI chr17:42,302,523...42,310,783
Ensembl chr17:42,302,540...42,310,783
JBrowse link
G Gmps guanine monophosphate synthase multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GMPS mRNA CTD PMID:19167446 NCBI chr 2:154,555,967...154,590,662
Ensembl chr 2:154,555,871...154,590,662
JBrowse link
G Gnai1 G protein subunit alpha i1 decreases expression ISO Coumestrol results in decreased expression of GNAI1 mRNA CTD PMID:19167446 NCBI chr 4:13,405,136...13,486,866
Ensembl chr 4:13,405,136...13,485,883
JBrowse link
G Gnaq G protein subunit alpha q decreases expression ISO Coumestrol results in decreased expression of GNAQ mRNA CTD PMID:19167446 NCBI chr 1:233,382,778...233,622,584
Ensembl chr 1:233,382,708...233,622,786
JBrowse link
G Gnl3l G protein nucleolar 3 like decreases expression ISO Coumestrol results in decreased expression of GNL3L mRNA CTD PMID:19167446 NCBI chr  X:20,037,558...20,070,505
Ensembl chr  X:20,034,882...20,070,578
JBrowse link
G Gns glucosamine (N-acetyl)-6-sulfatase decreases expression ISO Coumestrol results in decreased expression of GNS mRNA CTD PMID:19167446 NCBI chr 7:63,467,027...63,501,054
Ensembl chr 7:63,467,216...63,499,353
JBrowse link
G Golga2 golgin A2 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of GOLGA2 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GOLGA2 mRNA
CTD PMID:19167446 NCBI chr 3:11,317,328...11,337,569
Ensembl chr 3:11,317,183...11,336,458
JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1 increases expression
multiple interactions
ISO Coumestrol results in increased expression of GOT1 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GOT1 mRNA
CTD PMID:19167446 NCBI chr 1:263,246,248...263,269,762
Ensembl chr 1:263,246,248...263,269,762
JBrowse link
G Gpaa1 glycosylphosphatidylinositol anchor attachment 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPAA1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of GPAA1 mRNA CTD PMID:19167446 NCBI chr 7:117,394,367...117,397,950
Ensembl chr 7:117,394,372...117,397,956
JBrowse link
G Gpat4 glycerol-3-phosphate acyltransferase 4 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPAT4 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of GPAT4 mRNA CTD PMID:19167446 NCBI chr16:73,615,949...73,649,769
Ensembl chr16:73,615,949...73,649,767
JBrowse link
G Gpatch11 G patch domain containing 11 increases expression ISO Coumestrol results in increased expression of GPATCH11 mRNA CTD PMID:19167446 NCBI chr 6:1,410,461...1,421,506
Ensembl chr 6:1,410,507...1,423,041
JBrowse link
G Gpatch2l G patch domain containing 2-like decreases expression ISO Coumestrol results in decreased expression of GPATCH2L mRNA CTD PMID:19167446 NCBI chr 6:110,093,767...110,228,943
Ensembl chr 6:110,093,819...110,227,475
JBrowse link
G Gpatch4 G patch domain containing 4 increases expression ISO Coumestrol results in increased expression of GPATCH4 mRNA CTD PMID:19167446 NCBI chr 2:187,404,731...187,424,047
Ensembl chr 2:187,415,262...187,424,045
JBrowse link
G Gpd2 glycerol-3-phosphate dehydrogenase 2 increases expression ISO Coumestrol results in increased expression of GPD2 mRNA CTD PMID:19167446 NCBI chr 3:43,223,892...43,359,069
Ensembl chr 3:43,255,567...43,359,074
JBrowse link
G Gper1 G protein-coupled estrogen receptor 1 multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of GPER1 mRNA CTD PMID:19167446 NCBI chr12:17,309,122...17,315,267
Ensembl chr12:17,309,834...17,311,112
JBrowse link
G Gpr137b G protein-coupled receptor 137B decreases expression ISO Coumestrol results in decreased expression of GPR137B mRNA CTD PMID:19167446 NCBI chr17:90,670,852...90,709,003
Ensembl chr17:90,670,872...90,746,804
JBrowse link
G Gpr160 G protein-coupled receptor 160 decreases expression ISO Coumestrol results in decreased expression of GPR160 mRNA CTD PMID:19167446 NCBI chr 2:116,105,110...116,162,036
Ensembl chr 2:116,105,111...116,161,998
JBrowse link
G Gprc5a G protein-coupled receptor, class C, group 5, member A multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GPRC5A mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of GPRC5A mRNA
Coumestrol results in decreased expression of GPRC5A mRNA
CTD PMID:19167446 NCBI chr 4:168,832,937...168,851,650
Ensembl chr 4:168,832,910...168,851,652
JBrowse link
G Gprc5c G protein-coupled receptor, class C, group 5, member C decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of GPRC5C mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GPRC5C mRNA
CTD PMID:19167446 NCBI chr10:103,395,222...103,417,360
Ensembl chr10:103,395,511...103,417,358
JBrowse link
G Gpsm2 G-protein signaling modulator 2 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPSM2 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of GPSM2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of GPSM2 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of GPSM2 mRNA]
Coumestrol results in increased expression of GPSM2 mRNA
CTD PMID:18310284, PMID:19167446 NCBI chr 2:211,480,120...211,528,096
Ensembl chr 2:211,480,400...211,527,919
JBrowse link
G Gpx8 glutathione peroxidase 8 increases expression
multiple interactions
ISO Coumestrol results in increased expression of GPX8 mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of GPX8 mRNA
CTD PMID:19167446 NCBI chr 2:44,903,337...44,907,046
Ensembl chr 2:44,903,337...44,907,030
JBrowse link
G Gramd1a GRAM domain containing 1A multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GRAMD1A mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of GRAMD1A mRNA CTD PMID:19167446 NCBI chr 1:89,563,982...89,590,406
Ensembl chr 1:89,563,976...89,590,490
JBrowse link
G Grb10 growth factor receptor bound protein 10 decreases expression ISO Coumestrol results in decreased expression of GRB10 mRNA CTD PMID:19167446 NCBI chr14:92,021,851...92,122,249
Ensembl chr14:92,021,851...92,117,923
JBrowse link
G Greb1 growth regulating estrogen receptor binding 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GREB1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of GREB1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of GREB1 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of GREB1 mRNA]
Coumestrol results in increased expression of GREB1 mRNA
CTD PMID:18310284, PMID:19167446 NCBI chr 6:41,932,941...42,002,770
Ensembl chr 6:41,932,244...42,002,819
JBrowse link
G Grhl3 grainyhead-like transcription factor 3 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GRHL3 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of GRHL3 mRNA CTD PMID:19167446 NCBI chr 5:153,893,039...153,925,045
Ensembl chr 5:153,893,039...153,924,896
JBrowse link
G Grk6 G protein-coupled receptor kinase 6 increases expression ISO Coumestrol results in increased expression of GRK6 mRNA CTD PMID:19167446 NCBI chr17:9,705,917...9,721,921
Ensembl chr17:9,703,453...9,721,574
JBrowse link
G Grn granulin precursor multiple interactions ISO [Coumestrol co-treated with resveratrol] results in decreased expression of GRN mRNA CTD PMID:19167446 NCBI chr10:90,377,103...90,383,207
Ensembl chr10:90,376,933...90,383,205
JBrowse link
G Grpel1 GrpE-like 1, mitochondrial increases expression ISO Coumestrol results in increased expression of GRPEL1 mRNA CTD PMID:19167446 NCBI chr14:79,458,951...79,464,782
Ensembl chr14:79,458,963...79,464,770
JBrowse link
G Gtf2h4 general transcription factor 2H subunit 4 increases expression ISO Coumestrol results in increased expression of GTF2H4 mRNA CTD PMID:19167446 NCBI chr20:3,582,688...3,588,373
Ensembl chr20:3,582,742...3,588,375
JBrowse link
G Gtf2ird1 GTF2I repeat domain containing 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GTF2IRD1 mRNA CTD PMID:19167446 NCBI chr12:25,264,052...25,370,947
Ensembl chr12:25,264,192...25,371,001
JBrowse link
G Gtse1 G-2 and S-phase expressed 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GTSE1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of GTSE1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of GTSE1 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of GTSE1 mRNA]
Coumestrol results in increased expression of GTSE1 mRNA
CTD PMID:18310284, PMID:19167446 NCBI chr 7:126,736,416...126,753,221
Ensembl chr 7:126,736,732...126,753,220
JBrowse link
G Gulp1 GULP PTB domain containing engulfment adaptor 1 multiple interactions
decreases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GULP1 mRNA
Coumestrol results in decreased expression of GULP1 mRNA
CTD PMID:19167446 NCBI chr 9:51,263,484...51,538,066
Ensembl chr 9:51,263,622...51,538,072
JBrowse link
G H1f2 H1.2 linker histone, cluster member decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of H1-2 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of H1-2 mRNA
CTD PMID:19167446 NCBI chr17:43,638,938...43,640,445
Ensembl chr17:43,639,749...43,640,387
JBrowse link
G H2ax H2A.X variant histone multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of H2AX mRNA; [Coumestrol co-treated with Resveratrol] results in increased expression of H2AX mRNA
Coumestrol results in increased expression of H2AX mRNA; Coumestrol results in increased expression of H2AX protein modified form
CTD PMID:19167446, PMID:28986287 NCBI chr 8:48,665,652...48,666,981
Ensembl chr 8:48,665,652...48,666,981
JBrowse link
G H2az1 H2A.Z variant histone 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of H2AZ1 mRNA; [Coumestrol co-treated with Resveratrol] results in increased expression of H2AZ1 mRNA
Coumestrol results in increased expression of H2AZ1 mRNA
CTD PMID:19167446 NCBI chr 2:243,105,224...243,107,333
Ensembl chr 2:243,105,674...243,106,956
JBrowse link
G H2az2 H2A.Z variant histone 2 increases expression
multiple interactions
ISO Coumestrol results in increased expression of H2AZ2 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of H2AZ2 mRNA
CTD PMID:19167446 NCBI chr14:86,687,782...86,706,639
Ensembl chr14:86,687,782...86,706,626
JBrowse link
G H2bc12 H2B clustered histone 12 decreases expression ISO Coumestrol results in decreased expression of H2BC12 mRNA CTD PMID:19167446 NCBI chr17:44,527,421...44,527,801
Ensembl chr17:44,527,421...44,527,801
JBrowse link
G H2bc9 H2B clustered histone 9 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of H2BC9 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of H2BC9 mRNA
CTD PMID:19167446 NCBI chr17:44,519,815...44,520,269
Ensembl chr17:44,519,860...44,520,240
JBrowse link
G H3f3b H3.3 histone B multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of H3-3B mRNA CTD PMID:19167446 NCBI chr10:104,573,666...104,575,890
Ensembl chr10:104,573,664...104,575,890
JBrowse link
G Hadh hydroxyacyl-CoA dehydrogenase multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HADH mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of HADH mRNA
Coumestrol results in increased expression of HADH mRNA
CTD PMID:19167446 NCBI chr 2:236,353,445...236,395,067
Ensembl chr 2:236,353,445...236,395,067
JBrowse link
G Haspin histone H3 associated protein kinase multiple interactions ISO [Coumestrol co-treated with resveratrol] results in increased expression of HASPIN mRNA CTD PMID:19167446 NCBI chr10:59,695,403...59,698,398
Ensembl chr10:59,695,913...59,698,168
JBrowse link
G Hat1 histone acetyltransferase 1 increases expression ISO Coumestrol results in increased expression of HAT1 mRNA CTD PMID:19167446 NCBI chr 3:58,022,395...58,070,067
Ensembl chr 3:58,022,238...58,070,068
JBrowse link
G Haus1 HAUS augmin-like complex, subunit 1 multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HAUS1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of HAUS1 mRNA
Coumestrol results in increased expression of HAUS1 mRNA
CTD PMID:19167446 NCBI chr18:74,140,759...74,151,965
Ensembl chr18:74,187,162...74,198,369
JBrowse link
G Haus4 HAUS augmin-like complex, subunit 4 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HAUS4 mRNA CTD PMID:19167446 NCBI chr15:33,182,139...33,193,880
Ensembl chr15:33,182,128...33,193,537
JBrowse link
G Haus7 HAUS augmin-like complex, subunit 7 increases expression ISO Coumestrol results in increased expression of HAUS7 mRNA CTD PMID:19167446 NCBI chr  X:157,347,222...157,372,796
Ensembl chr  X:157,353,577...157,372,809
JBrowse link
G Haus8 HAUS augmin-like complex, subunit 8 increases expression
multiple interactions
ISO Coumestrol results in increased expression of HAUS8 mRNA
[Coumestrol co-treated with resveratrol] results in increased expression of HAUS8 mRNA
CTD PMID:19167446 NCBI chr16:19,654,785...19,669,221
Ensembl chr16:19,654,798...19,669,196
JBrowse link
G Hbp1 HMG-box transcription factor 1 decreases expression ISO Coumestrol results in decreased expression of HBP1 mRNA CTD PMID:19167446 NCBI chr 6:51,231,479...51,257,699
Ensembl chr 6:51,231,480...51,257,625
JBrowse link
G Hebp1 heme binding protein 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HEBP1 mRNA CTD PMID:19167446 NCBI chr 4:168,903,586...168,933,102
Ensembl chr 4:168,903,565...168,933,079
JBrowse link
G Hectd3 HECT domain E3 ubiquitin protein ligase 3 decreases expression ISO Coumestrol results in decreased expression of HECTD3 mRNA CTD PMID:19167446 NCBI chr 5:135,860,578...135,870,535
Ensembl chr 5:135,860,675...135,868,495
JBrowse link
G Hells helicase, lymphoid specific multiple interactions
increases expression
ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HELLS mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of HELLS mRNA
Coumestrol results in increased expression of HELLS mRNA
CTD PMID:19167446 NCBI chr 1:257,901,856...257,953,889
Ensembl chr 1:257,766,691...257,949,183
Ensembl chr 1:257,766,691...257,949,183
JBrowse link
G Helz2 helicase with zinc finger 2 decreases expression
multiple interactions
ISO Coumestrol results in decreased expression of HELZ2 mRNA
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HELZ2 mRNA
CTD PMID:19167446 NCBI chr 3:176,730,024...176,744,382
Ensembl chr 3:176,731,769...176,744,377
JBrowse link
G Herc1 HECT and RLD domain containing E3 ubiquitin protein ligase family member 1 multiple interactions ISO [Coumestrol co-treated with 2,3-bis(3'-hydroxyb